JPH041634B2 - - Google Patents
Info
- Publication number
- JPH041634B2 JPH041634B2 JP15131084A JP15131084A JPH041634B2 JP H041634 B2 JPH041634 B2 JP H041634B2 JP 15131084 A JP15131084 A JP 15131084A JP 15131084 A JP15131084 A JP 15131084A JP H041634 B2 JPH041634 B2 JP H041634B2
- Authority
- JP
- Japan
- Prior art keywords
- pulse
- skin
- current
- conductor
- polarization
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000004020 conductor Substances 0.000 claims description 58
- 230000010287 polarization Effects 0.000 claims description 35
- 230000007246 mechanism Effects 0.000 claims description 23
- 230000010355 oscillation Effects 0.000 claims description 18
- 239000003990 capacitor Substances 0.000 claims description 14
- 230000002999 depolarising effect Effects 0.000 claims description 4
- 230000006698 induction Effects 0.000 claims description 4
- 239000000499 gel Substances 0.000 description 52
- 210000003491 skin Anatomy 0.000 description 48
- 229940079593 drug Drugs 0.000 description 43
- 239000003814 drug Substances 0.000 description 43
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 22
- 239000000203 mixture Substances 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 16
- 239000000463 material Substances 0.000 description 13
- 238000010586 diagram Methods 0.000 description 12
- 239000011780 sodium chloride Substances 0.000 description 11
- 230000000694 effects Effects 0.000 description 10
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- UNPLRYRWJLTVAE-UHFFFAOYSA-N Cloperastine hydrochloride Chemical compound Cl.C1=CC(Cl)=CC=C1C(C=1C=CC=CC=1)OCCN1CCCCC1 UNPLRYRWJLTVAE-UHFFFAOYSA-N 0.000 description 8
- 239000006185 dispersion Substances 0.000 description 8
- 239000012153 distilled water Substances 0.000 description 8
- 235000011187 glycerol Nutrition 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol Chemical compound C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 description 8
- -1 gauze Substances 0.000 description 7
- 230000028161 membrane depolarization Effects 0.000 description 7
- 239000011505 plaster Substances 0.000 description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- 239000000853 adhesive Substances 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 6
- 239000004372 Polyvinyl alcohol Substances 0.000 description 5
- 206010040880 Skin irritation Diseases 0.000 description 5
- 229920002125 Sokalan® Polymers 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 229920001477 hydrophilic polymer Polymers 0.000 description 5
- 229920002451 polyvinyl alcohol Polymers 0.000 description 5
- 230000036556 skin irritation Effects 0.000 description 5
- 231100000475 skin irritation Toxicity 0.000 description 5
- 229920002554 vinyl polymer Polymers 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- 230000001070 adhesive effect Effects 0.000 description 4
- 239000011888 foil Substances 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 4
- 229960003712 propranolol Drugs 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000002390 adhesive tape Substances 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 229960001193 diclofenac sodium Drugs 0.000 description 3
- 238000001647 drug administration Methods 0.000 description 3
- UPBDXRPQPOWRKR-UHFFFAOYSA-N furan-2,5-dione;methoxyethene Chemical compound COC=C.O=C1OC(=O)C=C1 UPBDXRPQPOWRKR-UHFFFAOYSA-N 0.000 description 3
- 239000000017 hydrogel Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- IUBSYMUCCVWXPE-UHFFFAOYSA-N metoprolol Chemical compound COCCC1=CC=C(OCC(O)CNC(C)C)C=C1 IUBSYMUCCVWXPE-UHFFFAOYSA-N 0.000 description 3
- 229960002237 metoprolol Drugs 0.000 description 3
- 239000000025 natural resin Substances 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- 229920002401 polyacrylamide Polymers 0.000 description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 238000007127 saponification reaction Methods 0.000 description 3
- JGMJQSFLQWGYMQ-UHFFFAOYSA-M sodium;2,6-dichloro-n-phenylaniline;acetate Chemical compound [Na+].CC([O-])=O.ClC1=CC=CC(Cl)=C1NC1=CC=CC=C1 JGMJQSFLQWGYMQ-UHFFFAOYSA-M 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 229920003002 synthetic resin Polymers 0.000 description 3
- 239000000057 synthetic resin Substances 0.000 description 3
- 238000004804 winding Methods 0.000 description 3
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 2
- 229920000178 Acrylic resin Polymers 0.000 description 2
- 239000004925 Acrylic resin Substances 0.000 description 2
- 206010008570 Chloasma Diseases 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- RPTUSVTUFVMDQK-UHFFFAOYSA-N Hidralazin Chemical compound C1=CC=C2C(NN)=NN=CC2=C1 RPTUSVTUFVMDQK-UHFFFAOYSA-N 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 2
- 240000001058 Sterculia urens Species 0.000 description 2
- 235000015125 Sterculia urens Nutrition 0.000 description 2
- ZZHLYYDVIOPZBE-UHFFFAOYSA-N Trimeprazine Chemical compound C1=CC=C2N(CC(CN(C)C)C)C3=CC=CC=C3SC2=C1 ZZHLYYDVIOPZBE-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- VQODGRNSFPNSQE-DVTGEIKXSA-N betamethasone phosphate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COP(O)(O)=O)(O)[C@@]1(C)C[C@@H]2O VQODGRNSFPNSQE-DVTGEIKXSA-N 0.000 description 2
- 229950006991 betamethasone phosphate Drugs 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 230000008713 feedback mechanism Effects 0.000 description 2
- 210000000245 forearm Anatomy 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 238000010030 laminating Methods 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 230000000737 periodic effect Effects 0.000 description 2
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 2
- 239000004584 polyacrylic acid Substances 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 2
- 235000010378 sodium ascorbate Nutrition 0.000 description 2
- 229960005055 sodium ascorbate Drugs 0.000 description 2
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 2
- 229960004025 sodium salicylate Drugs 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 2
- 229960001727 tretinoin Drugs 0.000 description 2
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 1
- CEMAWMOMDPGJMB-UHFFFAOYSA-N (+-)-Oxprenolol Chemical compound CC(C)NCC(O)COC1=CC=CC=C1OCC=C CEMAWMOMDPGJMB-UHFFFAOYSA-N 0.000 description 1
- XWTYSIMOBUGWOL-UHFFFAOYSA-N (+-)-Terbutaline Chemical compound CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1 XWTYSIMOBUGWOL-UHFFFAOYSA-N 0.000 description 1
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 229930003347 Atropine Natural products 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- GJSURZIOUXUGAL-UHFFFAOYSA-N Clonidine Chemical compound ClC1=CC=CC(Cl)=C1NC1=NCCN1 GJSURZIOUXUGAL-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-N Nitrous acid Chemical compound ON=O IOVCWXUNBOPUCH-UHFFFAOYSA-N 0.000 description 1
- 241000287127 Passeridae Species 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 1
- HCBIBCJNVBAKAB-UHFFFAOYSA-N Procaine hydrochloride Chemical compound Cl.CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 HCBIBCJNVBAKAB-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000006359 acetalization reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000003522 acrylic cement Substances 0.000 description 1
- 239000002313 adhesive film Substances 0.000 description 1
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 description 1
- 229960003790 alimemazine Drugs 0.000 description 1
- 229960002213 alprenolol Drugs 0.000 description 1
- PAZJSJFMUHDSTF-UHFFFAOYSA-N alprenolol Chemical compound CC(C)NCC(O)COC1=CC=CC=C1CC=C PAZJSJFMUHDSTF-UHFFFAOYSA-N 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000003416 antiarrhythmic agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- 229960000396 atropine Drugs 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 229960004980 betanidine Drugs 0.000 description 1
- NIVZHWNOUVJHKV-UHFFFAOYSA-N bethanidine Chemical compound CN\C(=N/C)NCC1=CC=CC=C1 NIVZHWNOUVJHKV-UHFFFAOYSA-N 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 230000037058 blood plasma level Effects 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229960004782 chlordiazepoxide Drugs 0.000 description 1
- ANTSCNMPPGJYLG-UHFFFAOYSA-N chlordiazepoxide Chemical compound O=N=1CC(NC)=NC2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 ANTSCNMPPGJYLG-UHFFFAOYSA-N 0.000 description 1
- SOYKEARSMXGVTM-UHFFFAOYSA-N chlorphenamine Chemical compound C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 SOYKEARSMXGVTM-UHFFFAOYSA-N 0.000 description 1
- 229960003291 chlorphenamine Drugs 0.000 description 1
- 229960001076 chlorpromazine Drugs 0.000 description 1
- ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 description 1
- YNNUSGIPVFPVBX-NHCUHLMSSA-N clemastine Chemical compound CN1CCC[C@@H]1CCO[C@@](C)(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 YNNUSGIPVFPVBX-NHCUHLMSSA-N 0.000 description 1
- 229960002881 clemastine Drugs 0.000 description 1
- 229960003120 clonazepam Drugs 0.000 description 1
- DGBIGWXXNGSACT-UHFFFAOYSA-N clonazepam Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)CN=C1C1=CC=CC=C1Cl DGBIGWXXNGSACT-UHFFFAOYSA-N 0.000 description 1
- 229960002896 clonidine Drugs 0.000 description 1
- 229960001338 colchicine Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 229960004833 dexamethasone phosphate Drugs 0.000 description 1
- VQODGRNSFPNSQE-CXSFZGCWSA-N dexamethasone phosphate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)COP(O)(O)=O)(O)[C@@]1(C)C[C@@H]2O VQODGRNSFPNSQE-CXSFZGCWSA-N 0.000 description 1
- 229960001259 diclofenac Drugs 0.000 description 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 1
- 108700023753 digipramine Proteins 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 239000007772 electrode material Substances 0.000 description 1
- 239000008151 electrolyte solution Substances 0.000 description 1
- 229940021013 electrolyte solution Drugs 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- OFKDAAIKGIBASY-VFGNJEKYSA-N ergotamine Chemical compound C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@@](C(N21)=O)(C)NC(=O)[C@H]1CN([C@H]2C(C3=CC=CC4=NC=C([C]34)C2)=C1)C)C1=CC=CC=C1 OFKDAAIKGIBASY-VFGNJEKYSA-N 0.000 description 1
- 229960004943 ergotamine Drugs 0.000 description 1
- XCGSFFUVFURLIX-UHFFFAOYSA-N ergotaminine Natural products C1=C(C=2C=CC=C3NC=C(C=23)C2)C2N(C)CC1C(=O)NC(C(N12)=O)(C)OC1(O)C1CCCN1C(=O)C2CC1=CC=CC=C1 XCGSFFUVFURLIX-UHFFFAOYSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000001030 gas--liquid chromatography Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229960003602 guanethidine Drugs 0.000 description 1
- ACGDKVXYNVEAGU-UHFFFAOYSA-N guanethidine Chemical compound NC(N)=NCCN1CCCCCCC1 ACGDKVXYNVEAGU-UHFFFAOYSA-N 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 229960002474 hydralazine Drugs 0.000 description 1
- MPGBPFMOOXKQRX-UHFFFAOYSA-N indenolol Chemical compound CC(C)NCC(O)COC1=CC=CC2=C1C=CC2 MPGBPFMOOXKQRX-UHFFFAOYSA-N 0.000 description 1
- 229950008838 indenolol Drugs 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000012212 insulator Substances 0.000 description 1
- 229920000831 ionic polymer Polymers 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229960001317 isoprenaline Drugs 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 229960004503 metoclopramide Drugs 0.000 description 1
- TTWJBBZEZQICBI-UHFFFAOYSA-N metoclopramide Chemical compound CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC TTWJBBZEZQICBI-UHFFFAOYSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 1
- 229960001597 nifedipine Drugs 0.000 description 1
- 150000002826 nitrites Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229960004570 oxprenolol Drugs 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000037368 penetrate the skin Effects 0.000 description 1
- 231100000435 percutaneous penetration Toxicity 0.000 description 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 229960001309 procaine hydrochloride Drugs 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 229950001574 riboflavin phosphate Drugs 0.000 description 1
- 229960002052 salbutamol Drugs 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 229960003339 sodium phosphate Drugs 0.000 description 1
- RPACBEVZENYWOL-XFULWGLBSA-M sodium;(2r)-2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate Chemical compound [Na+].C=1C=C(Cl)C=CC=1OCCCCCC[C@]1(C(=O)[O-])CO1 RPACBEVZENYWOL-XFULWGLBSA-M 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229960000195 terbutaline Drugs 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 230000000304 vasodilatating effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
Landscapes
- Electrotherapy Devices (AREA)
Description
æ¬çºæã¯ã€ãªã³ãããªã¬ãŒãŒçšããã€ã¹ã«é¢ã
ãã ã€ãªã³æ§è¬å€ã®çµç®åžåãä¿é²ããå¹æçãªå±
ææè¬æ¹æ³ãšããŠãã€ãªã³ãããªã¬ãŒãŒã¯è¿æ
çã 泚ç®ããã€ã€ããïŒGlass JM et al.ïŒInt.J.
Dermatol.19 519ïŒ1980ïŒïŒRusso J.ïŒAm.J.
Hosp.Pharm.37 843ïŒ1980ïŒGangarosa LP et
al.ïŒJ.Pharmacol.Exp.Ther.212 377ïŒ1980ïŒïŒ
Kwon BS et al.ïŒJ.Infect.Dis.140 1014
ïŒ1979ïŒïŒHill JM et al.ïŒAnn.NY.Acad.Sci.284
604ïŒ1977ïŒåã³Tannebaum M.Phys.Ther.60
792ïŒ1980ïŒãçã ïŒã ãããå è¡æè¡ã«æŒããã€ãªã³ãããªã¬ãŒãŒ
ã¯ãéåžžãæç¶å¹³æµçºçè£ çœ®åã¯æç¶å¹³æµçºçè£
眮ã®åºå端åãšãè¬æ¶²å«æµžè±è綿çã§éå±æ¿çã®
å°äœã被èŠããŠæãé¢å°ååã³é¡äŒŒæ§æã®äžé¢å°
åãšãé£ç¶ããŠãªããããã®ã§ãããããã®å®æœ
ã¯ããªãç ©éã§ãããæè¬æ¹æ³ãšããŠæ¥µããŠæå¹
ãªãã®ã§ããã«ãæããããã®æ®åã¯éå®ããã
ããåŸãªããã®ã§ãã€ãããŸãããã®ã€ãªã³ãã
ãªã¬ãŒãŒã¯æäžããè¬å€ã®æ¥µæ§ãšåäžã®æ¥µæ§ãæ
ã€æç¶å¹³æµãŸãã¯æç¶å¹³æµãå©çšããŠäœ¿çšããã
ã®ã§ããããç®èã¯ç¬¬ïŒå³ã®ç®èç䟡åè·¯å³ã«ç€º
ãããã«ããªãŒã æµæRdcãšãå極æµæRpolãš
å極容éCpolãšããæãå極ã€ã³ããŒãã³ã¹ïŒº
ãšãæããŠããããã®ãªãŒã æµæRdcãå°ãé»æµ
è·¯ãšããäŸãã°æç¶å¹³æµçã®éåžžã®ã€ãªã³ãããª
ã¬ãŒãŒã«ãããŠã¯Rdcã極ããŠé«æµæã§ãããã
æ²»çã«å¿ èŠãªéã®è¬å€ãæäžããã«ã¯ãé«é»å§ã
ç®èã«å°å ããªããã°ãªããããã®ããç®èã«å¯Ÿ
ããåºæ¿ã匷ããããã©ïŒçºèµ€çãåŒèµ·ããæã
ããã€ããããã«ãç®èã®æå·é²æ¢ãèæ ®ããäœ
é»å§ã§è¡ãªããšå¿ èŠéã®æäžã¯æ¥µããŠå°é£ãªãã®
ã§ãã€ãã ãŸããåèšç®èã®ãªãŒã æµæRdcã¯é»æºã®åš
æ³¢æ°ã«äŸåããªã10KΩã»cmã1MΩã»cmçšåºŠã®
åçŽæµæã§ããããå極ã€ã³ããŒãã³ã¹ïŒºã¯äœ¿çš
ããé»å§ã®åšæ³¢æ°ãäŸãã°10KHz以äžã®å Žåå®è³ª
çã«ãŒãã«åæããããšãç¥ãããŠããã
ïŒYamamotoïŒet al.ïŒMed.ïŒ Biol.Eng.ïŒ
Comput.ïŒïŒ1978ïŒ16.592â594ïŒå±±æ¬ãïŒïŒå»çš
é»åãšçäœå·¥åŠïŒæå48幎ïŒç¬¬11巻第ïŒå·337â
342.ïŒ åŸã€ãŠé«ãåšæ³¢æ°ã®é»å§ã人äœã«å°å ãããšå
極ã€ã³ããŒãã³ã¹ïŒºã¯äœäžããããäœé»å§ã§ã®ã€
ãªã³ãããªã¬ãŒãŒãå¯èœãšãªããã®ã§ããããç®
èã®å極ã€ã³ããŒãã³ã¹ïŒºã¯ç¬¬ïŒå³ã®ç®èç䟡
åè·¯å³ã«ç€ºãããã«å極æµæRpolãšå極容é
Cpolãšã®äžŠååè·¯ã§è¡šããããããã第ïŒå³ïœ
ã«ç€ºããããªçŽæµãã«ã¹ãåã«å°å ããŠããå極
容éCpolã¯å é»ïŒæŸé»ãç¹°è¿ãããã«ã¹åºåã®
äŒæ¢æã«ãå é»ãããæ®åé»è·ïŒå極ïŒãå極æµ
æRpolãä»ããŠæ¥µããŠç·©æ ¢ã«æŸé»ïŒè±å極ïŒã
ãããã第ïŒå³ïœã«ç€ºãããã«è¬å€å°å ¥ã«ä¿ãã
é»æµã¯å®è³ªçã«æç¶å¹³æµã䜿çšããå Žåãšå€ãã
ç¡ããã®ãšãªããåšæ³¢æ°ã®é«ãçŽæµãã«ã¹ãåã«
å°å ããŠãç®èã€ã³ããŒãã³ã¹ã®äœäžã¯èµ·ããåŸ
ãªããã®ã§ãã€ãã ãŸãã第ïŒå³ïœã«ç€ºãããã«çŽæµãã«ã¹ã®åºå
æéãçãããå極容éCpolã«ããæ®åé»è·
ïŒå極ïŒãçããŠããé»æµå€ãå åäœããªããŸã§
ã®ãã«ã¹ã®äŒæ¢æéã®ééãåºããããšã«ããã
ããªãã¡ããŠãŒãã€æ¯ãå°ããããããšã«ããç®
èã€ã³ããŒãã³ã¹ïŒºãäœãããããšãèãããã
ããæ®åé»æ¥µïŒå極ïŒã¯ç®èäžã«æ®åããé»è·ã§
ããè¬å€æäžã«ã¯é¢äžããªãããå°å ¥å¹çã®ç¹ã§
åé¡ãæãããã®ã§ãã€ãã æ¬çºæã¯ãäžèšæ¬ ç¹ã解æ¶ãããã®ã§ãç®èã€
ã³ããŒãã³ã¹ãå åã«äœäžããããšãã§ãããã
ã«ããäœé»å§ãé«é»æµã§ã®äœ¿çšãå¯èœã«ããæŽã«
ã¯é«é»å§å°å ã«æŒããŠãç®èã«å¯Ÿããåºæ¿ãå°ãª
ãããã©ãçºèµ€çã®æããç¡ãå®å šãªã€ãªã³ãã
ãªã¬ãŒãŒçšããã€ã¹ãæäŸããããšãç®çãšã
ãã ãŸããæ¬çºæã¯ãæ²»çãã«ã¹åºåæã«å極容é
ã«è²¯ããããæ®åé»è·ãæå¹ã«ååããããšã«ã
ãäœé»åæ¶è²»ã®ã€ãªã³ãããªã¬ãŒãŒçšããã€ã¹ã
æäŸããããšãç®çãšããã ããã«æ¬çºæã¯å°åœ¢è»œéã®ã€ãªã³ãããªã¬ãŒãŒ
çšããã€ã¹ãç¹ã«äººäœç®èã«çŽæ¥è²ŒçãåŸã極ã
ãŠæäœç°¡åäžã€è»œéæ§é ã®ã€ãªã³ãããªã¬ãŒãŒçš
ããã€ã¹ãæäŸããããšãç®çãšããã 以äžãæ¬çºæã®ç¬¬ïŒã®å®æœäŸãå³é¢ç¬¬ïŒå³ä¹è³
第ïŒå³ãåç §ããŠè©³çŽ°ã«èª¬æããã 第ïŒå³ã«ãããŠïŒã¯ãããã¯å³ã§ç€ºããã€ãªã³
ãããªã¬ãŒãŒçšããã€ã¹ã§ãããïŒã¯é»æºäŸãã°
ïŒïŒ»ïŒ¶ïŒœã®ä¹Ÿé»æ± ã§ãããïŒã¯ãã«ã¹çºæ¯æ©æ§ã§ã
第ïŒå³ïœã«ç€ºããããªäŸãã°50KHzçšåºŠã®çŽæµã
ã«ã¹ãçºæ¯ããããã®æ©æ§ã§ãããïŒã¯ã€ãªã³æ§
è¬å€ãå«æããé¢å°åã§ãïŒã¯äžé¢å°åã§ããã
ïŒã¯ãåèšé¢å°åïŒåã³äžé¢å°åïŒã«æ¥ç¶ããã
人äœã§ããã ïŒã¯æ®åé»è·ååçšãã€ãã·ã¿ã§ãé»æºïŒãšäžŠ
åã«æ¥ç¶ãããŠãããïŒã¯ã€ã³ãã¯ã¿ã§ãããã
ã®ã€ã³ãã¯ã¿ïŒã¯ã¹ã€ããæ©æ§ïŒã«æ¥ç¶ãããŠã
ãããã®ã¹ã€ããæ©æ§ïŒã¯ãåèšãã«ã¹çºæ¯æ©æ§
ïŒããåºåãããæ²»çãã«ã¹ïŒïŒïŒïŒïŒïŒâŠã®äŒ
æ¢ãšåæã«ã第ïŒå³ã«ç€ºãæ®åé»è·ãååããã
ãã®éåè·¯ããªãã¡ã€ã³ãã¯ã¿ïŒãäž¡å°åïŒïŒïŒ
ã«çŽåã«æ¥ç¶ãããéåè·¯ã圢æããããã«èšã
ããããã®ã§ããã«ã¹çºæ¯æ©æ§ïŒã«äžŠåã«æ¥ç¶ã
ããŠããã 次ã«ããã®ããæ§æãããæ¬çºæã€ãªã³ãããª
ã¬ãŒãŒçšããã€ã¹ã®äœ¿çšæ¹æ³åã³äœçšã説æã
ãããŸãã人äœïŒã«é¢å°åïŒåã³äžé¢å°åïŒã貌
çããããã®æäœã«ãã第ïŒå³ã«ç€ºãè¬å€å°å ¥å
è·¯ã圢æããããããªãã¡ããã«ã¹çºæ¯æ©æ§ïŒã¯
第ïŒå³ïœã«ç€ºããã«ã¹ïŒïŒãåºåããããã®ãã«
ã¹ïŒïŒã®åºåæéã®éã人äœïŒã®ç®èã®äž»ãš
ããŠå極ã€ã³ããŒãã³ã¹ïŒºã«é»æµã¯æµãïŒãã«ã¹
é»æµIaïŒïŒé¢å°åïŒã®ã€ãªã³æ§è¬å€ã¯äž»ãšããŠå
極æµæRpolãéããŠçµç®åžåãããããããŠæ²»
çãã«ã¹ïŒïŒãäŒæ¢ãããšåæã«ããªãã¡ãã«ã¹
çºæ¯æ©æ§ïŒãOFFã«ãªããšåæã«ã¹ã€ããæ©æ§
ïŒã¯ONãã第ïŒå³ã«ç€ºãæ®åé»è·åååè·¯ã圢
æãããããã®åè·¯ã«ãããæ²»çãã«ã¹ïŒïŒã®åº
åæã«äººäœïŒã®ç®èã®å極ã€ã³ããŒãã³ã¹ïŒºã®
å極容éCpolã«å é»ãããæ®åé»è·ã¯ãå極容
éCpolãšã€ã³ãã¯ã¿ïŒãšã®ïŒ¬âïŒ£å ±æ¯ã«ããã
æ®åé»è·ååçšãã€ãã·ã¿ïŒã«ååãããããã
ãŠãã®ååãããé»è·ã¯ã次ã®æ²»çãã«ã¹ïŒïŒã®
åºåæã«æŸé»ãããããŸãããã®äœçšã¯ãå極容
éCpolã«å é»ãããæ®åé»è·ïŒå極ïŒãæ²»çã
ã«ã¹ïŒïŒã®äŒæ¢æéã«æŸé»ïŒè±å極ïŒããããšã«
ãªãïŒè±å極é»æµIbïŒãäž¡å°åéã®é»äœã¯æå®å€
以äžã奜ãŸããã¯çã¬ãã«ã«ãªãã å°ãäžèšå®æœäŸã«ãããŠã¯ãè±å極ãããšãšã
ã«æ®åé»è·ãååããæ段ãšããŠïŒ¬âïŒ£å ±æ¯ãå©
çšãããã®ã«ã€ããŠèª¬æããããããã«éå®ãã
ããã®ã§ã¯ç¡ããåã«æ®åé»è·ååçšãã€ãã·ã¿
ãèšãããã®ã§ãã€ãŠãè¯ãããŸãâïŒ£å ±æ¯ã«
ããååããæ§æçãæ®åé»è·ãååã§ããæ§æ
ã§ããã°ãããªãæ段ã§ãã€ãŠãè¯ãã ããã«ãè¬å€å°å ¥å¹çãæ®æé»è·ååå¹çãè
æ ®ãããã©ã³ã¹ïŒãã€ãŒãžãã³ãåŒæå§åè·¯ïŒ
DCâDCã³ã³ããŒã¿çã®ãã«ã¹é»å§ãæå§ããã
ãã®æ©æ§ãèšãããã®ã§ãã€ãŠãè¯ãããŸãæ²»ç
ãã«ã¹ã®ç«äžãç«äžãæã«ã人äœã«å€§ããªããŒã¯
é»æµãæµãããããã®ããŒã¯é»æµãå¶éãããã
ã®åºåé»æµå¶éåè·¯ãèšãããã®ã§ãã€ãŠãè¯
ãã ããã«ãé»æºé»å§ã»ãã«ã¹å·Ÿåã³çºæ¯åšæ³¢æ°ã
å°å ¥ããè¬å€ã®ç¹æ§ãçšéã«å¿ãä»»æã«å€æŽãã
ãã®ã§ãã€ãŠãè¯ãããéåžžãããŠãŒãã€æ¯0.1
ã0.7ãåšæ³¢æ°1KHzã500KHzçšåºŠã®å€ãæ¡çšã
ãã奜ãŸããã¯ããŠãŒãã€æ¯0.1ã0.4ãåšæ³¢æ°5K
Hzã200KHzã奜é©ã«äœ¿çšããåŸãããŸãããã
ããå¯å€ããããã®æ©æ§ãèšãå人差ã«ãã埮調
æŽãå«ããã³ã³ãããŒã«ããªããªãŒãã§ãããã
ã«ãããã®ã§ãã€ãŠãè¯ãã ãŸããæ¬çºæã§èšãè±å極ã®çšåºŠã¯ãç®èã«å®
åžžçã«å°å ãããããšã«ãªãæ®åå極é»å§ãç®è
ã€ãªããŒã·ãšã³ïŒåºæ¿ïŒãçèµ·ããªãç¯å²å ã§ã
ãã°è¶³ãã䜿çšãã«ã¹é»å§çã®äœ¿çšè«žæ¡ä»¶ã«ãã€
ãŠé©å®æ±ºå®ããåŸããã®ã§ããããéåžžã奜ãŸã
ãã¯æ®åé»å§ïŒïŒ»ïŒ¶ïŒœä»¥å ããã奜ãŸããã¯1.5
以å ã§ããã ããããã«ã¹é»æµéã«å¯Ÿããè±å極é»æµéã®æ¯
ã§ç€ºãã°ãéåžžãè±å極é»æµéã¯ãã«ã¹é»æµéã®
çŽ50ïŒ ä»¥äžã奜ãŸããã¯60ïŒ ä»¥äžããã奜ãŸãã
70ïŒ ä»¥äžã§ããã ããã«ãä»ã®èŠ³ç¹ããããã°ãè±å極é»æµå€ã
å®è³ªçã«ãŒãã¬ãã«ã«è¿æ¥ããå®åžžå€ã«ãªãçšåºŠ
ã®ç¯å²ã奜ãŸããã ä»æ¹ãç®èã€ãªããŒã·ãšã³ïŒåºæ¿ïŒã®çèµ·ããª
ãç¯å²å ã§ããã°ããã«ã¹é»å§ãšåæã«äžå®ã®å®
åžžãã€ã¢ã¹é»å§çãæŽã«å°å ãããŠããŠãããã
ãšã¯æããã§ããããããªãã¡ããã«ã¹ã»ã€ãªã³
ãããªã¬ãŒãŒãšåŸ®åŒ±ãªå¹³æµã€ãªã³ãããªã¬ãŒãŒã¯
åèšç¯å²å ã§äœµçšããåŸãã ãŸããäžèšå®æœäŸã«ãããŠã¯ãç®èç䟡åè·¯ã®
äžè¬çäŸã«ã€ããŠèª¬æããããå°åã®é»æ°çç¹æ§
ãèæ ®ããå Žåãç¥åæ§ã®ããšãèšããã 以äžã®èª¬æã§æãããªããã«æ¬çºæã€ãªã³ãã
ãªã¬ãŒãŒçšããã€ã¹ã«ããã°ãæç¶å¹³æµãŸãã¯å
ãªãæç¶å¹³æµã䜿çšãããã®ã«æ¯èŒããŠãåãé»
æºé»å§ãå°å ããå Žåç¥10æ°åãæ°10åã®é»æµã
æµããããšã«ãªããæ°åãæ°10åã®ã€ãªã³æ§è¬å€
å°å ¥å¹æãåŸãããããŸããäœé»å§ã§å¿ èŠéã®è¬
å€æäžãã§ãããããæãã¯ãäŸãã°50ç
ã®é«é»å§å°å ã«ãããŠããç®èã«å¯Ÿããåºæ¿ãè
ãã匱ããããã©ãçºèµ€çã®æãããå°ãªããã
ãã«é·æéã®äœ¿çšã«ãé©ããã€ãªã³ãããªã¬ãŒãŒ
çšããã€ã¹ãåŸãããã ããã«ãç®èã®å極容éã«è²¯ããããæ®åé»è·
ã¯è¬å€å°å ¥ã«ã¯é¢äžããªãç¡é§ãªé»è·ã§ãããã
æ¬çºæã€ãªã³ãããªã¬ãŒãŒçšããã€ã¹ã«ããã°ã
æ®åé»è·ã極ããŠæå¹ã«ååãã次ã®æ²»çãã«ã¹
åºåæã«æŸé»ãããæ§æãšããããèããé»åæ¶
è²»ã軜æžãããå¹æãæããããŸãäœé»åæ¶è²»ã®
ãããæ¯èŒçå°å®¹éã§å°åã®é»æ± ã§æå®ã®è¬å€å°
å ¥ãã§ããããããã€ã¹èªäœã®å°å軜éåã«ã極
ããŠæå¹ãªãã®ãšãªãåŸãã å°ã以äžã¯å®çšäžã®èŠ³ç¹ããåšæçãã«ã¹ã«ã€
ããŠèª¬æããããæ¬è³ªçã«ã¯éåšæçãã«ã¹ã«ã
ã€ãŠãåçã®å¹æãåŸããããã®ã§ããããšåã³
ãã«ã¹æ³¢åœ¢çã¯ç©åœ¢æ³¢ã«éå®ãããéæã§ããã
ãšã¯åœç¶ã§ããã 次ã«æ¬çºæã€ãªã³ãããªã¬ãŒãŒçšããã€ã¹ã®å
æ§æèŠçŽ åã³å®æœåœ¢æ çã«ã€ããŠãã詳现ã«èª¬æ
ããã 第ïŒå³ã¯ãã«ã¹é»å§ãæå§ãããã©ã³ã¹ãèš
ãããã®ãã©ã³ã¹ã®ïŒæ¬¡åŽå·»ç·ãã€ã³ãã¯ã¿ãšã
ãŠå©çšãããã®ã€ã³ãã¯ã¿ãšè² è·å®¹éãšã®ïŒ¬â
å ±æ¯ã«ãããè² è·å®¹éã®æ®åé»è·ãè±å極ãããš
ãšãã«ååããããã«ããåè·¯ã®äžå®æœäŸã§ã
ããå³ã«ãããŠãïŒã¯é»æºã§ãããã€ã¹ïŒå šäœã
å°å軜éåããããã«äŸãã°ãã¿ã³ç¶ã«åœ¢æãã
ãïŒïŒ»ïŒ¶ïŒœã®ãªããŠã é»æ± ã䜿çšããŠããããã®
é»æºïŒã¯ãã«ã¹çºæ¯æ©æ§ïŒã«æ¥ç¶ãããŠãããã
ã®ãã«ã¹çºæ¯æ©æ§ïŒã¯äŸãã°éå®å®ãã«ããã€ã
ã¬ãŒã¿åè·¯ã§åœ¢æãããŠãããåšæ³¢æ°50KHzïŒã
ãŠãŒãã€æ¯0.2ã®ãã«ã¹ãåºåããããã«æ§æã
ããŠãããïŒïŒã¯ãã©ã³ã¹ã§ããããã®ãã©ã³ã¹
ïŒïŒã¯ãã«ã¹é»å§ãæå§ããããã«èšããããã
ã®ã§äŸãã°å·»ç·æ¯ãïŒïŒïŒã«æ§æãããŠããããŸ
ãããã®ãã©ã³ã¹ïŒïŒã®ïŒæ¬¡åŽã¯ïŒ¬âïŒ£å ±æ¯çšã®
ã€ã³ãã¯ã¿ïŒãšããŠäœçšããããã«æ§æãããŠã
ããïŒã¯ã¹ã€ããã³ã°ãã©ã³ãžã¹ã¿ã§ããããã®
ã¹ã€ããã³ã°ãã©ã³ãžã¹ã¿ïŒã¯ãåèšãã«ã¹çºæ¯
æ©æ§ïŒããã®ãã«ã¹åºåã«ããåèšãã©ã³ã¹ïŒïŒ
ã®ïŒæ¬¡åŽãONâOFFããããã«èšãããããã®
ã§ãããïŒïŒã¯åè·¯ä¿è·çšã®ãã€ãªãŒãã§ããã
ïŒã¯æ®åé»è·ååçšã®ãã€ãã·ã¿ããªãã¡ã³ã³ã
ã³ãµã§ãããïŒïŒïŒã¯é¢å°ååã³äžé¢å°åã§äººäœ
ïŒã«æ¥ç¶ãããŠãããæ¬å®æœäŸã®äœçšåã³å¹æã¯
äžèšå®æœäŸãšåäžã®ãããã®èª¬æãçç¥ããã 次ã«ç¬¬ïŒå³ãåç §ããŠæ¬çºæã€ãªã³ãããªã¬ãŒ
ãŒçšããã€ã¹ã®åè·¯ã®ç¬¬ïŒã®å®æœäŸã詳现ã«èª¬æ
ãããåèšç¬¬ïŒã®å®æœäŸãšåäžéšåã«ã¯åäžç¬Šå·
ãä»ããŠãã®èª¬æãçç¥ããã æ¬å®æœäŸã¯èªå°é»æµãèªèµ·ããããã®ãã©ã³ã¹
ãèšãããã®ãã©ã³ã¹ã®äœçšã«ããè² è·å®¹éã®æ®
åé»è·ãè±å極ãããšãšãã«ååããããã«ãã
åè·¯ã§ãããå³ã«ãããŠïŒïŒã¯èªå°é»æµèªèµ·ãã©
ã³ã¹ã§ããããã®ãã©ã³ã¹ïŒïŒã¯ïŒæ¬¡åŽã®äž¡å°å
ïŒïŒïŒéã«çŽåã«æ¥ç¶ãããïŒæ¬¡åŽïŒïŒã¯ãéé»
æµé²æ¢çšã®ãã€ãªãŒãïŒïŒãä»ããŠïŒæ¬¡é»æ± ïŒïŒ
ã«æ¥ç¶ãããŠãããïŒã¯ãã«ã¹çºæ¯æ©æ§ã§ãåèš
ïŒæ¬¡é»æ± ïŒïŒã«æ¥ç¶ããããšãšãã«ç¬¬ïŒåã³ç¬¬ïŒ
ã®FETïŒïŒïŒïŒïŒã®ã²ãŒãã«æ¥ç¶ãããŠããã 次ã«æ¬å®æœäŸã®äœçšã説æããããŸãããã«ã¹
çºæ¯æ©æ§ïŒã¯ïŒæ¬¡é»æ± ïŒïŒãé»æºãšããŠç¬¬ïŒå³ã«
瀺ããããªãã«ã¹ïŒïŒãçºçããããã®ãã«ã¹ïŒ
ïŒã®ç«äžããšåæã«FETïŒïŒã®ãã¬ã€ã³âãœãŒ
ã¹éã¯å°éãããåŸã€ãŠããã«ã¹ïŒïŒã®åºåæé
ã®éã人äœïŒã®ç®èã®äž»ãšããŠå極ã€ã³ããŒ
ãã³ã¹ïŒºã«é»æµã¯æµãïŒãã«ã¹ã¹é»æµIaïŒïŒé¢å°
åïŒã®ã€ãªã³æ§è¬å€ã¯äž»ãšããŠå極æµæRpolã
éããŠçµç®åžåãããããããŠãã«ã¹ïŒïŒãäŒæ¢
ãããšåæã«FETïŒïŒã¯OFFãšãªããFETïŒïŒ
ã¯å°éãããåŸã€ãŠãå極ã€ã³ããŒãã³ã¹ïŒºã®å
極容éCpolã«å é»ãããæ®åé»è·ã¯ãèªå°é»æµ
èªèµ·ãã©ã³ã¹ïŒïŒã®ïŒæ¬¡åŽïŒïŒãå«ãéåè·¯ã«ã
ãç¬æã«è±å極ããããåæã«ãã©ã³ã¹ïŒïŒã«ã
ãïŒæ¬¡åŽïŒïŒã«ã¯èªå°é»æµãèªèµ·ãããããã®èª
å°é»æµã¯ãã€ãªãŒãïŒïŒãä»ããŠïŒæ¬¡é»æ± ïŒïŒã®
å¹çè¯ãååãããã å°ãäžèšå®æœäŸã«ãããŠã¯æ®åé»è·ãïŒæ¬¡é»æ±
ã«ååãããã®ã«ã€ããŠèª¬æããããã³ã³ãã³ãµ
ã«ååãããããããã®ã§ãã€ãŠãè¯ãããŸãèª
å°é»æµèªèµ·å¹çãïŒæ¬¡é»æ± ãŸãã¯ã³ã³ãã³ãµãžã®
å é»å¹çãèæ ®ãããã©ã³ã¹ã®å·»ç·æ¯ãé©å®å€æ
ãããã®ã§ãã€ãŠãè¯ãã 次ã«æ¬çºæã€ãªã³ãããªã¬ãŒãŒçšããã€ã¹ã®å š
äœæ§æã®å®æœäŸã以äžã«è©³è¿°ããã 第ïŒå³åã³ç¬¬ïŒïŒå³ã¯ç¬¬ïŒã®å®æœäŸã瀺ããå³
ã«ãããŠïŒïŒã¯ç®èäžäœè²Œçåããªãã¡ãã©ã¹ã¿
ãŒåœ¢ç¶ã«æ§æããã€ãªã³ãããªã¬ãŒãŒçšããã€ã¹
ã§ãé¢å°åïŒïŒãšäžé¢å°åïŒïŒãšãæããŠããã
åèšé¢å°åïŒïŒã¯ãæè»ã·ãŒãä¹è³ãã€ã«ã ç¶ã«
圢æããã€ãªã³æ§è¬å€å«æå°é»æ§ã²ã«å±€ïŒïŒãšã
ã¢ã«ãããŠã ç®çã®éå±ç®ïŒå°é»æ§ãŽã ä¹è³æš¹è
ãã€ã«ã ãŸãã¯ã«ãŒãã³ãã€ã«ã ãå°é»å¡æçã§
圢æãããé»æµåæ£çšå°é»æ§éšæå±€ïŒïŒãšãç©å±€
ããŠäžäœçã«åœ¢æãããã®ã§ããããŸããäžé¢å°
åïŒïŒã¯æè»ã·ãŒãä¹è³ãã€ã«ã ç¶ã«åœ¢æããã
å°é»æ§ã²ã«å±€ïŒïŒãšãåèšãšåæ§ã¢ã«ãããŠã ç®
çã§åœ¢æãããé»æµåæ£çšå°é»æ§éšæå±€ïŒïŒãšã
ç©å±€ããŠäžäœçã«åœ¢æãããã®ã§ãããåèšé¢å°
åïŒïŒã®äžé¢ç¥äžå€®éšã«ã¯ãã¯ãŒãµãã©ã€ãŠãã
ãïŒïŒãèšçœ®ãããŠããããã®ãã¯ãŒãµãã©ã€ãŠ
ãããïŒïŒã«ã¯ãé»æºäŸãã°ãããããã¿ã³ç¶é»
æ± ãšããã«ã¹çºæ¯æ©æ§ãšããã®ãã«ã¹çºæ¯æ©æ§ã®
æ²»çãã«ã¹äŒæ¢æã«åèšäž¡å°åïŒïŒïŒïŒïŒã®é»äœ
ãçã¬ãã«ã«ããããã®æ段åã³æ®åé»è·ãåå
ããããã®æ段ãšãå èšãããŠããããã®äžæ¹ã®
åºå端åäŸãã°ïŒâïŒç«¯åãé»æµåæ£çšå°é»æ§éš
æå±€ïŒïŒã«æ¥è§Šããããã«èšçœ®ãããŠããããŸã
ãã®ãã¯ãŒãµãã©ã€ãŠãããïŒïŒã®ïŒïŒïŒç«¯åã¯
ãã®äž¡ç«¯è¿åãé€ãäžé¢ã«çµ¶çžã³ãŒãã€ã³ã°ãæœ
ããäŸãã°ã¢ã«ãããŠã ç®ã®ãªãŒãç·ïŒïŒã«ãã
åèšäžé¢å°åïŒïŒã®é»æµåæ£çšå°é»æ§éšæå±€ïŒïŒ
ã«æ¥ç¶ãããŠãããïŒïŒã¯çµ¶çžæ§ãããã³ã°å±€ã§
ããããã®çµ¶çžæ§ãã«ãã³ã°å±€ïŒïŒã¯äŸãã°éå°
é»æ§ã®åææš¹èãæè»ã·ãŒãä¹è³ãã€ã«ã ç¶ã«åœ¢
æãããã®ã§ãåèšé¢å°åïŒïŒåã³äžé¢å°åïŒïŒ
ã¯ãã®çµ¶çžæ§ãããã³ã°å±€ïŒïŒã«é¢éããŠé 眮åº
çãããŠãããããªãã¡ãé¢å°åïŒïŒïŒäžé¢å°å
ïŒïŒåã³ãã¯ãŒãµãã©ã€ãŠãããïŒïŒã¯çµ¶çžæ§ã
ããã³ã°å±€ïŒïŒã«ããäžäœçã«æ¯æé£çµãããŠã
ãã 次ã«ãã®ããã«æ§æããã€ãªã³ãããªã¬ãŒãŒçš
ããã€ã¹ã®äœçšåã³äœ¿çšæ³ã説æããããŸã人äœ
ã®æ²»çåžæäœçœ®ã«é¢å°åïŒïŒãåœæ¥ããããã«è²Œ
çããããããšåæã«é¢å°åïŒïŒãšäžé¢å°åïŒïŒ
ãšã¯éåè·¯ã圢æãããã«ã¹çºæ¯ãéå§ãããŠé¢
å°åïŒïŒã®ã€ãªã³æ§è¬å€å«æå°é»æ§ã²ã«å±€ïŒïŒäž
ã®ã€ãªã³æ§è¬å€ã®çµç®æµžéã¯å éãããã æ¬å®æœäŸã«ãããšã人äœç®èã«çŽæ¥è²ŒçãåŸã
極ããŠæäœç°¡åäžã€è»œéã§ãå åãªè¬å€æäžå¹æ
ã®åŸãããã€ãªã³ãããªã¬ãŒãŒçšããã€ã¹ãåŸã
ããã 次ã«ç¬¬ïŒïŒå³åã³ç¬¬ïŒïŒå³ãåç §ããŠæ¬çºæã€
ãªã³ãããªã¬ãŒãŒçšããã€ã¹ããç®èäžäœè²Œçå
ããªãã¡ãã©ã¹ã¿ãŒåœ¢ç¶ã«æ§æãã第ïŒã®å®æœäŸ
ã«ã€ããŠè©³çŽ°ã«èª¬æãããå³ã«ãããŠïŒïŒã¯ã€ãª
ã³ãããªã¬ãŒãŒçšããã€ã¹ã§ãïŒïŒã¯é¢å°åãïŒ
ïŒã¯äžé¢å°åã瀺ãããã®é¢å°åïŒïŒåã³äžé¢å°
åïŒïŒã®é»æµåæ£çšå°é»æ§éšæå±€ïŒïŒïŒïŒïŒã¯ïŒ
mmçšåºŠé¢éããŠé 眮ãããŠããããã®äžé¢ã«ã¯äŸ
ãã°0.3mmçšåºŠã®æ¥µèã«åœ¢æãããã€ãªã³æ§è¬å€
å«æå°é»æ§ã²ã«å±€ïŒïŒãäžäœã«è²ŒçãããŠããã
ãŸããäžé¢å°åïŒïŒåã³é¢å°åïŒïŒã¯çµ¶çžæ§ãã
ãã³ã°å±€ïŒïŒã«ããäžäœçã«æ¯æé£çµãããŠã
ããïŒïŒåã³ïŒïŒã¯åã é¢å°åïŒïŒïŒäžé¢å°åïŒ
ïŒã«æ¥ç¶ããã端åã§ããããã®ç«¯åïŒïŒïŒïŒïŒ
ã®é éšã¯åèšçµ¶çžæ§ãããã³ã°å±€ïŒïŒã貫éããŠ
çªåºããŠããããã¯ãŒãµãã©ã€ãŠãããïŒïŒã¯ã
ã®ç«¯åïŒïŒïŒïŒïŒã«ããé»æ°çã«æ¥ç¶ããããšãš
ãã«æ©æ¢°çã«æ¯æé£çµãããã æ¬å®æœäŸã®ã€ãªã³ãããªã¬ãŒãŒçšããã€ã¹ã®äœ¿
çšæ¹æ³ã¯åèšç¬¬ïŒã®å®æœäŸãšåäžã®ããçç¥ã
ããæ¬å®æœäŸã«ãããšé¢å°åïŒïŒåã³äžé¢å°åïŒ
ïŒã«ç©å±€é 眮ããå°é»æ§ã²ã«å±€ãåäžããªãã¡äž
æã®ã€ãªã³æ§è¬å€å«æå°é»æ§ã²ã«å±€ïŒïŒãåé»æµ
åæ£çšå°é»æ§éšæå±€ïŒïŒïŒïŒïŒã«è²Œçããæ§æãš
ãããããåå°åéã«è¥å¹²ã®ãªãŒã¯é»æµãçãã
ããå°é»æ§ã²ã«å±€èªäœãæµæãæããŠããå°é»æ§
éšæå±€ïŒïŒïŒïŒïŒéã®è·é¢ãå°é»æ§ã²ã«å±€ïŒïŒã®
åãã«å¯ŸããŠæ¥µããŠå€§ããããã€ãªã³æ§è¬å€ã®ç®
è浞éå¹æã«ã¯ã»ãšãã©åœ±é¿ãçããªãã æ¬å®æœäŸã«ãããšãåèšç¬¬ïŒã®å®æœäŸã®å¹æã®
ä»ã«ãã®è£œé å·¥çšã極ããŠç°¡æäžã€èœççã«ãªã
å¹æãæãããããªãã¡ãå°é»æ§ã²ã«å±€ïŒå°é»æ§
éšæå±€ïŒçµ¶çžæ§ãããã³ã°å±€ãç©å±€é 眮ããäžæ¬
ã®åž¯ç¶ã·ãŒããæå®ã®ééããã€ãŠåæãããã®
ã«ç«¯ååã³ãã¯ãŒãµãã©ã€ãåä»ããã®ã¿ã§ãã
ã€ã¹ãåŸãã倧éçç£ãèæ ®ããå Žåã«ãããŠé
åžžã«æçšãªå¹æãå¥ãããããã«å®æœäŸã®ããã«
䞡端åã®é 眮ééãçããããã€ã¹äžé¢ã®ç¥äžå€®
éšã«ãã¯ãŒãµãã©ã€ãé 眮ãããšãããã€ã¹å šäœ
ã«å¯Ÿãããã¯ãŒãµãã©ã€ã®å€§ããã®åœ±é¿ã¯ã»ãšã
ã©ç¡ããã®ãšãªãã人äœã®æ²é¢éšã«è²Œçããå Žå
ã«ãããŠãæè»æ§ãã»ãšãã©æãªããã«è¯å¥œã«äœ¿
çšããããšãã§ããã 次ã«å³é¢ç¬¬ïŒïŒå³ãåç §ããŠæ¬çºæã€ãªã³ãã
ãªã¬ãŒãŒçšããã€ã¹ã®ç¬¬ïŒã®å®æœäŸã詳现ã«èª¬æ
ãããå³ã«ãããŠïŒïŒã¯ã€ãªã³ãããªã¬ãŒãŒçšã
ãã€ã¹ã§ãïŒïŒã¯äžé¢å°åã瀺ããïŒïŒã¯ãã¯ãŒ
ãµãã©ã€ã§ããã®ïŒâïŒç«¯åã¯é¢å°åïŒïŒã®é»æµ
åæ£çšå°é»æ§éšæå±€ïŒïŒã«æ¥ç¶ããããŸãïŒïŒïŒ
端åã¯ãªãŒãç·ïŒïŒãä»ããŠäžé¢å°åïŒïŒã®é»æµ
åæ£çšå°é»æ§éšæå±€ïŒïŒã«æ¥ç¶ãããŠããã æ¬å®æœäŸã®æ§æã«ãããšãé¢å°åãšäžé¢å°åãš
ã¯ãªãŒãç·ã®é·ãã®ç¯å²ã§ä»»æã«é¢ããŠäººäœã«è²Œ
çããããšãã§ãã貌çéšäœãå°ããå Žåãæ¯èŒ
ç倧ããªæ²çã®é¢ã«ãç¡çç¡ã䜿çšããããšãã§
ããããŸããé«æž©å€æ¹¿æã«äœ¿çšããç®èãå€éã«
çºæ±ããå Žåããåå°åã¯é¢ããŠããããè¡šç®ã
æµããé»æµã®åœ±é¿ãå šãåããªããã©ã¹ã¿ãŒæ§é
äœãåŸãããã 次ã«å³é¢ç¬¬ïŒïŒå³ãåç §ããŠæ¬çºæã€ãªã³ãã
ãªã¬ãŒãŒçšããã€ã¹ã®ç¬¬ïŒã®å®æœäŸã詳现ã«èª¬æ
ãããå³ã«ãããŠïŒïŒã¯ã€ãªã³ãããªã¬ãŒãŒçšã
ãã€ã¹ã§ãïŒïŒã¯ãã®é¢å°åãïŒïŒã¯äžé¢å°åã
瀺ãããã®äž¡å°åïŒïŒïŒïŒïŒã¯ãªãŒãç·ïŒïŒãä»
ããŠãã¯ãŒãµãã©ã€ïŒïŒã«æ¥ç¶ãããŠããããã®
ãã¯ãŒãµãã©ã€ïŒïŒã«ã¯é»æºäŸãã°åäžåœ¢ä¹Ÿé»æ±
ïŒæ¬ãšããã©ã³ã¹ãå©çšãããã«ã¹çºæ¯æ©æ§å
ã³ãæ²»çãã«ã¹ã®äŒæ¢æã«äž¡å°åïŒïŒïŒïŒïŒã®é»
äœãçã¬ãã«ã«ããããã®äŸãã°ã¹ã€ããæ©æ§ãš
æ®åé»è·ãååããããã®æ段ãšãå èšãããŠã
ããããã«ãã®ãã¯ãŒãµãã©ã€ïŒïŒã«ã¯åºåé»æµ
å¯å€åè·¯ãšã¿ã€ããŒåè·¯ãšãå èšãããŠããã æ¬å®æœäŸã«ãããšããã¯ãŒãµãã©ã€ãäž¡å°åãš
å¥äœã«ãããããåè·¯ã¹ããŒã¹çã«äœè£ãã§ã倧
容éã®ä¹Ÿé»æ± ã䜿ãããšãã§ããããŸãäž¡å°åã¯
åãªããã€ã«ã ç¶ã®è¶ 軜éã·ãŒããšãªããã人äœ
ãžã®è²Œçã極ããŠå®¹æã«ãªããããã«åºåé»æµå¯
å€åè·¯ãå èšããããã䜿çšè ã®ç®èæµæãå°å ¥
ããè¬å€ã®çš®é¡ãå¿ èŠéçã«ããä»»æã«åºåé»æµ
éãã³ã³ãããŒã«ããããšãã§ããããŸãã¿ã€ã
ãŒåè·¯ãèšãããããè¬å€ã®éå°æäžãé²ãããš
ãã§ããçã®å¹æãæããã å°ãäžèšå®æœäŸã«ãããŠã¯ãé¢å°åã«ã€ãªã³æ§
è¬å€ãå«æããå°é»æ§ã²ã«ã䜿çšãããã®ã«ã€ã
ãŠèª¬æããããããã«éå®ããããã®ã§ã¯ç¡ãã
åžæ°ŽçŽçã®çŽæãã¬ãŒãŒçã®åžæãè±è綿çã®ç¹
ç¶æãåææš¹èé£ç¶çºæ³¡äœãŸãã¯åžæ°Žæ§æš¹èçã®
ã¹ãã³ãžä¹è³å€å質æçã€ãªã³æ§è¬å€ä¹è³é»è§£è³ª
液ãå«æµžä¿æã§ãããã®ã§ããã°ãããªããã®ã§
ãã€ãŠãè¯ãããŸããå®æœäŸã«ãããŠã¯é¢å°åã®
å°é»æ§ã²ã«å±€ã«ãããããã€ãªã³æ§è¬å€ãå«æã
ããã®ã«ã€ããŠèª¬æããããã€ãªã³æ§è¬å€ã¯äœ¿çš
æã«å°åããã³ïŒãŸãã¯ç®èã«ä»äžããããã«ã
ããã®ã§ãã€ãŠãè¯ããããªãã¡ãå°é»æ§ã²ã«å±€
ã«ã¯ã€ãªã³æ§è¬å€ãå«æããŠããªããã®ã䜿çšã
æ²»çéå§æã«ã€ãªã³æ§è¬å€ãå«æããè»èãã¯ãª
ãŒã çãå°åããã³ïŒãŸãã¯ç®èã«å¡ä»ãç®è圢
æãããåŸãå°åã貌çãæ²»çãè¡ãªãããã«ã
ãã€ãªã³ãããªã¬ãŒãŒçšããã€ã¹ã§ãã€ãŠãè¯
ããããã«ãæå¹è¬å€ã€ãªã³çš®ã®é°éœã«å¿ããŠå°
åã®é°éœãèªåšã«å€æãåŸãã¹ã極æ§åææ段ã
åœè©²ããã€ã¹ã«ä»å ãããã®ã§ãã€ãŠãããã ãŸãããšãã«è¬å€æäžéã«å¿ããŠçäœã®ç¶æ³ã
å€åããå Žåããçäœã®ç¶æ³ã«å¿ããŠè¬å€æäžé
ãå¶åŸ¡ããªããŠã¯ãããªãå Žåã«ãããŠã¯ãåèš
çäœç¶æ³ãç£èŠããªããåºåé»æµãèªåçã«å¶åŸ¡
ããããã®ãã€ãŒãããã¯æ©æ§ãå èšããæ§æã«
ãããã®ã§ãã€ãŠãè¯ããäŸãã°ãç¹ã«ã€ã³ã·ãŠ
ãªã³ã®æäžã®ããã«ãè¡æ¶²äžã®è¡ç³å€ã«ããæäž
éãå¶åŸ¡ããå¿ èŠã®ããå Žåã«ã¯ãè¡ç³å€ãç£èŠ
ããã»ã³ãµãŒããã¯ãŒãµãã©ã€ã«æ¥ç¶ãããã®ã»
ã³ãµãŒã®æ€ç¥åºåã«ããèªåçã«åºåé»æµãã
ã³ïŒãŸãã¯åºåæéçãå¶åŸ¡ãããã€ãŒãããã¯
æ©æ§ãèšãããã®ã§ãã€ãŠãè¯ãããã®ããã«æ§
æããå Žåã¯åŸæ¥ã®æäžæ¹æ³ã§ã¯å°åºãªãåŸãªã
ã€ãçäœç¶æ³ã«å¿ããæé©ãªè¬å€æäžãè¡ãªãã
ãšãã§ããã æ¬äŸãã©ã¹ã¿ãŒæ§é äœã®åæ§æèŠçŽ çã«ä»ãæŽ
ã«è©³çŽ°ã«å説ããã°æ¬¡ã®éãã§ããã å°é»æ§ã²ã«å±€ ãã®å±€ã¯å¥œé©ã«ã¯ãã«ã©ã€ã¬ã ïŒãã©ã¬ã«ã³ã
ã¬ã ïŒã¶ã³ãµã³ã¬ã¹çã®å€©ç¶æš¹èå€ç³é¡åã¯ããª
ããã«ã¢ã«ã³ãŒã«éšåã±ã³åç©ïŒããªããã«ãã«
ããŒã«ïŒããªããã«ã¡ãã«ãšãŒãã«åã³ãã®ã³ãŒ
ããªãïŒããªããã«ãããªãã³ïŒããªããã«ã¡ã¿
ã¯ãªã¬ãŒãçã®ããã«ç³»æš¹èïŒããªã¢ã¯ãªã«é žå
ã³ãã®ãããªãŠã å¡©ïŒããªã¢ã¯ãªã«ã¢ããåã³ã
ã®éšåå æ°Žå解ç©ïŒããªã¢ã¯ãªã«é žãšã¹ãã«éšå
ã±ã³åç©ïŒããªïŒã¢ã¯ãªã«é žâã¢ã¯ãªã«ã¢ããïŒ
çã®ã¢ã¯ãªã«ç³»æš¹èãªã©ã芪氎æ§ãæããå皮倩
ç¶åã¯åææš¹èé¡ãæ°Žåã³ïŒåã¯ãšãã¬ã³ã°ãªã³
ãŒã«ïŒã°ãªã»ãªã³çã®ã¢ã«ã³ãŒã«é¡ã§æè»å¯å¡å
ããŠèªå·±ä¿åœ¢æ§ãç®èæ¥çæ§ãæããæè»ãã€ã«
ã ä¹è³ã·ãŒãç¶ã²ã«ãšããŠæäŸãããã ä»æ¹ãããã«å åãªå°é»æ§ãä»äžãã¹ãå¡©åã
ããªãŠã ïŒçé žãããªãŠã ïŒãããé žã«ãªãŠã
çã ã®é»è§£è³ªãæçšéïŒéåžžïŒã15ïŒ çšåºŠïŒæ·»å
ãããããã®ããã«ããŠåŸãããæ¬çºæã§å¥œé©ãª
å°é»æ§ã²ã«å±€ã¯ãæè»ãã€ã«ã ä¹è³ã·ãŒãç¶ã§ã
ã€ãŠç®èã«å¯çãåŸããã®ã§ãããããç®èæ¥è§Š
æµæãäœãè¬å€ã€ãªã³ã®çµç®æµžéã«å¹æçã§ãã
ã®ã¿ãªãããæ¥çããŒãçã®ä»ã®ç®èæ¥çæ段ã
èŠããæ§é äœå šäœãç®èã«è²Œçæ¯æãåŸããšãã
䜿çšäžã®å©ç¹ãã䜵ãæãããã®ã§ãããç¹ã«ã²
ã«å±€ã®åºæãšããŠåèšã«ã©ã€ã¬ã¹çã®å€©ç¶æš¹èå€
ç³é¡ã䜿çšããå Žåã¯ããã®å€©ç¶é«ååé žæ§é ã«
ããPHç·©è¡æ§ä¹è³ç®èä¿è·æ§ãèããé«ãä¿æ°Žèœ
åãé©åºŠãªç®èç²çæ§çã«ãããåã«é»æ°ååŠç
ã«è¯å¥œãªå°é»æ§ã²ã«ãæäŸãåŸãã®ã¿ãªãã奜é©
ãªç®èé©åæ§ãåŸããããã®ã§ããã åããããã²ã«å±€ã®çµæé åã«åœã€ãŠã¯ãæè¬
é»æ°æ³³åçšã²ã«ã®å Žåãšã»ãŒåæ§ã®é»æ°ååŠçé
æ ®ããªãããã¹ãããšã¯åœç¶ã§ããããäž»ãšããŠ
䜿çšè¬å€ã®çš®é¡ãšæèŠæäžéïŒçšéïŒã貌ç䜿çš
æéã䜿çšé»æ± ã®åºååã³ç®èæ¥è§Šé¢ç©çã ã«ã
ãããã®ã€ãªã³ã»ã¢ããªãã€ä¹è³é»å°åºŠãæèŠå€
ã«ãªãããé©å®å®æœããããã®ã§ããã ããã§ãæ¬äŸã«æŒãã奜é©ãªå°é»æ§ã²ã«å±€ã®ã¿
ãªãã幟ã€ããããå ·äœçã«ç€ºãã°äžèšã®éãã§
ããïŒ ïŒ åžžæ³ã«ãããå¹³åååé44äžãã±ã³å床çŽ60
ïŒ ã®ããªããã«ã¢ã«ã³ãŒã«ç²æ«30ïœã調補ãã
ããã«äºã80âã«å ç±ããã10ïŒ NaClå«æèž
çæ°Ž40ïœåã³ã°ãªã»ãªã³30ïœãæ·»å ãæ¹æãã
次ãã§åŸãããæ··åç©ã80âã«å ç±ããããã
ããã¬ã¹æ©ã«ããå§å0.6KgïŒcm2ã§çŽ20åéå
ç±å å§ããŠåãïŒmmã®æè»ã·ãŒãç¶ç©ãåŸãã
ãã®æè»ã·ãŒãç¶ç©ã¯å åãªç®èæ¥çæ§ãæã
äžã€ãã®çŽæµæ¯æµæïŒä»¥äžãåæ§ïŒã¯0.8K
Ωã»cmã§ãã€ãã ïŒ äžèšïŒãšåæ§ã«ããŠäžèšçµæã«ããæè»ã·ãŒ
ãç¶ã®å°é»æ§ã²ã«å±€ã補é ããã çµæäŸ ïŒ¡ ããªããã«ãããªãã³ïŒGAF瀟補PVPâ
K90ïŒå¹³åååé36äžïŒ âŠâŠ20ïœ 10ïŒ NaClå«æèžçæ°Ž âŠâŠ40ïœ ã°ãªã»ãªã³ âŠâŠ40ïœ åŸãããã·ãŒãã¯åŒ·ãç®èæ¥çæ§ãæãäž
ã€ãã®æ¯æµæã¯0.2KΩã»cmã§ãã€ãã çµæäŸ ïŒ¢ ããªããã«ãã«ããŒã«ïŒå¹³åååé160äžïŒ
ãã«ããŒã«å床15ïŒ ïŒåæããªããã«ã¢ã«ã³
ãŒã«ã®ã±ã³å床60ïŒ ïŒ âŠâŠ15ïœ ïŒïŒ NaClå«æèžçæ°Ž âŠâŠ70ïœ ãããã¬ã³ã°ãªã³ãŒã« âŠâŠ15ïœ åŸãããã·ãŒãã¯å åãªç®èæ¥çæ§ãæ
ãããã®æ¯æµæã¯1.0KΩã»cmã§ãã€ãã çµæäŸ ïŒ£ ããªããã«ã¢ã»ãã¢ã»ã¿ãŒã«ïŒå¹³åååé44
äžïŒã¢ã»ã¿ãŒã«å床30ïŒ ïŒåºçºããªããã«ã¢
ã«ã³ãŒã«ã®ã±ã³å床70ïŒ ïŒ âŠâŠ40ïœ 15ïŒ NaClå«æèžçæ°Ž âŠâŠ50ïœ ãšãã¬ã³ã°ãªã³ãŒã« âŠâŠ10ïœ å åãªç®èç²çæ§ãæããæ¯æµæ0.75K
Ωã»cmã ïŒ ããªã¢ã¯ãªã«é žãœãŒãïŒæ¥æ¬çŽè¬ç€Ÿè£œã¢ãã³
ãã¹SSïŒå¹³åååé300ã500äžïŒ20ïœãïŒïŒ
NaClå«æèžçæ°Ž12ïœåã³ã°ãªã»ãªã³æº¶æ¶²68ïœ
ãšåäžã«æ··åãã80âã§10åéå ç±å å§ããŠæ
è»ã·ãŒãç¶ç©ãåŸãããã®ã·ãŒãã¯é©åºŠã®ç®è
æ¥çæ§ãæãäžã€ãã®æ¯æµæã¯ïŒæŒå€æŸçœ®åŸã§
0.5KΩã»cmã§ãã€ãã ïŒ ã«ã©ã€ã¬ã¹30ïœãšïŒïŒ NaClå«æèžçæ°Ž30ïœ
åã³ã°ãªã»ãªã³40ïœãšãæ··åããå ç±å å§ããŠ
åæ§ã«ã·ãŒããäœæãããæ¯æµæ0.65KΩã»
cmã ïŒ ããªã¢ã¯ãªã«é žãœãŒãïŒæ¥æ¬çŽè¬ç€Ÿè£œã¢ãã³
ãã¹ïŒ³ïŒå¹³åååé300ã500äžïŒ20ïœãïŒïŒ
NaClå«æ粟補氎80ïœãšæ··åãå ç±å å§ããŠå
æ§ã«ã·ãŒããäœæãããæ¯æµæ0.47KΩã»cmã ãŸããç¹ã«é»æ°ååŠç芳ç¹ããããã°ããã©ã
ã©ãããŒã«ïŒã€ã³ã¹ãªã³ïŒãªãã«ã€ã³ïŒã·ã¹ãã€
ã³çã®å¡©åºæ§è¬å€ã¯ããªã¢ã¯ãªã«é žãã¡ãã«ãã
ã«ãšãŒãã«ã»ç¡æ°Žãã¬ã€ã³é žå ±éåäœïŒG.A.F.
瀟補GANTREZR ANâ169çïŒãã«ã«ããã·ã
ãªãšãã¬ã³ïŒGOODRICH瀟補CARBOPOLR
çïŒçã®é žæ§é«ååããåãã¢ã¹ã³ã«ãã³é žããµ
ãªãã«é žãäºç¡é žããªã³é žãªããã©ãã³ããªã³é ž
ãã¿ã¡ã¿ãŸã³ããã¬ããã€ã³ïŒtransâretinoic
acidïŒçã ã®é žæ§è¬å€ã¯ããªã¢ã¯ãªã«ã¢ããçã®
å¡©åºæ§é«ååãåã ã²ã«åºæãšããããšã«ããç®
çè¬å€ã®é«èœçã®ç§»åãéæãåŸãããšãç解ã
ãããã äŸãã°ãããã©ãããŒã«çšã²ã«çµæã®äžäŸã瀺
ãã°äžèšã®éãã§ããã ã«ãŒãããŒã«R 491åã¯GANTREZR ANâ
169 30éééš ã°ãªã»ãªã³ 45éééš æ°Ž 15éééš ãããã©ãããŒã« 10éééš æŽã«ããã®ã²ã«çµæç©ãåãçŽ0.1ã0.5mmçšåºŠ
ã®èªå·±æ¥çæ§ãã€ã«ã ãšãããã®ã¯ãåèšã®éã
é¢å°åã»äžé¢å°åäžäœåãã€ã«ã é»æ¥µãšããŠäœ¿çš
ã«æ¥µããŠå¥œé©ãšãªãã æŽã«åãããªããã«ã¢ã«ã³ãŒã«ãããªããã«ã
ããªãã³çã ã®éã€ãªã³æ§é«ååãåãé»æ°ååŠ
çã«æ¯èŒçé«å¹çã®ã²ã«ãæäŸãåŸããã®ã§ãã
ããšãç解ããããã äžèšããæãããªéããæ¬çºæå°é»æ§ã²ã«å±€ã®
ã²ã«åºæçµæä¹è³ç¯å²ã¯ç¹å®ã®ãã®ã«éå®ããã
ãã®ã§ã¯ãªãåºæ±ãªèŠªæ°Žæ§é«ååé¡ãæ°Žåã³ïŒå
ã¯ã¢ã«ã³ãŒã«é¡ã«ãŠæè»å¯å¡åããŠäœ¿çšã«äŸãã
ããã®ã§ããããéåžžãä¿åœ¢æ§ãæããããã«ã¯
芪氎æ§é«åå10ã70ééïŒ åã³æ®éšæ°Žåã³ïŒåã¯
ã¢ã«ã³ãŒã«ã®çµæç¯å²å ã§éžæå®æœããããäžèš
äŸç€ºã®åå°é»æ§ã²ã«å±€ã¯ããèªäœãå åãªç®èç²
çæ§ãæãããã®ã§ããããææã®å Žåãã¢ã¯ãª
ã«ç³»ç²çå€ãé ¢é žããã«ãšãã«ãžãšã³ç³»ç²çå€ç
ã®æå§æ§ç²çæåãæŽã«æ·»å ããŠãããã ãã®ããã«ãæ§é äœã®åšèŸºéšä¹è³ç«¯éšçã«ç®è
æ¥çæ§äžã€å°é»æ§ã®ã²ã«å±€ãé 眮ããããšã«ã
ããæ¥çããŒãçã®ä»ã®åºå®æ段ãäœãèŠããã«
åœè©²æ§é äœå šäœãç®èã«åºå®ä¿æãããã å°ãå°é»æ§ã²ã«å±€ãé¢å°åã®å€«ã§ããå Žåã¯ã
åæ²åã²ã«çµæäžãé»è§£è³ªæåãå³ã¡å¡©åãããª
ãŠã ã®ïŒéšåã¯å šéšã«ä»£ããŠæèŠã®ã€ãªã³æ§è¬å€
ãæ·»å 溶åããããã°è¶³ãããã®ã§ãããæèŠã®
å Žåãä¿æ°Žæ§éšæå±€ãçè±èªåšã«ããäºãè¬æ¶²å«
浞æžã®åœè©²éšæã䜿çšæã«æ§é äœæå®äœçœ®ã«é
眮ãæœè¡äœ¿çšããŠããããåãåžæ°Žæ§éšæã«ä»£ã
ãŠãå¯å€©ã²ã«ïŒãŒã©ãã³ã²ã«çã®é»æ°æ³³ååéã§
æ±çšã®éç²çæ§ãã€ããã²ã«ã䜿çšããŠãããã
ãšã¯æããã§ãããå¯å€©æ°Žã²ã«çµæã®ïŒäŸã瀺ã
ã°æ¬¡ã®éãã§ããã å¯å€©æ°Ž 4.0éééš ç²Ÿè£œæ°Ž 100.0 ã ãã¿ãã³ïŒ£ 5.0 ã ïŒã¢ã¹ã³ã«ãã³é žïŒãã®Naå¡©ãïŒïŒïŒïŒ ãã®çš®ã®ãã€ããã²ã«çã¯ãäºãæ§é äœã«ç©å±€
é 眮ãããŠããããæãã¯åè¿°ã®éã䜿çšæã«é
眮ãããããã«ããŠãããã å°ããã®ããã«å¯å€©ã²ã«çã®éç²çæ§ãã€ãã
ã²ã«ã䜿çšããå Žåã¯ãæ¬äŸã®æ§é äœå€å»¶éšåã«
æŽã«æ¥çããŒãçã®ç®èç²çæ§åºå®æ段ãä»»æã«
ä»å ããããã®ã§ããããšã¯åœç¶ã§ããã ã€ãªã³æ§è¬å€ ã€ãªã³è§£é¢æ§è¬å€ã§ããã°å šãŠäœ¿çšãåŸããã
ã€ãªã³ãããªã¬ãŒãŒåéã«æŒããŠæ¢ã«æ±çšãããŠ
ãããã®ã®ïŒéšãäŸç€ºããã°æ¬¡ã®éãã§ããïŒãš
ãŒãã«ãªïŒå¡©é žããã«ã€ã³ïŒã¡ãªã³ãŒã«ïŒãã¿ã
ã³B1ïŒB2ïŒB6ïŒïŒ£çã®åçš®ç®èãã¿ãã³ïŒãã¹
ã¿ãã³ïŒãµãªãã«é žãããªãŠã ïŒãããµã¡ã¿ãŸ
ã³ïŒãªã³é žãã¿ã¡ã¿ãŸã³ïŒãšããããšãªã³ïŒãã€
ããã³ã«ããªã³ïŒã€ãã¯ãœãªãžã³ïŒãããã©ãã
ãŒã«ïŒäºç¡é žå¡©ïŒãã¬ãªãã€ã·ã³ïŒãŠã³ãã·ã¬ã³
å¡©é žïŒãããµã¡ã¿ãŸã³ãªã³é žãšã¹ãã«ã®ãããªãŠ
ã å¡©ïŒãã¬ãããŸãã³ãªã³é žãããªãŠã ïŒã¢ãªã¡
ããžã³ïŒã¯ãã«ããšãã©ãã³ïŒã¯ã¬ãã¹ãã³ïŒãž
ãã³ã¯ã©ããïŒã³ã«ããã³ïŒãžã¯ãããšããã¯ïŒ
ã¯ãã«ããããžã³ïŒã¯ãã«ãžã¢ãŒããã·ãïŒã¯ã
ããŒãã ïŒããžãã©ãã³ïŒã€ãœãã©ãã³ïŒã¢ãã
ãã³ïŒãšã«ãŽã¿ãã³ïŒãããšãžãã³ïŒã¢ã«ãã¬ã
ããŒã«ïŒã€ã³ããããŒã«ïŒãªã¯ã¹ãã¬ãããŒã«ïŒ
ã€ãœãã¬ããªã³ïŒãããã©ãããŒã«ïŒãã¿ããž
ã³ïŒã¯ãããžã³ïŒã°ã¢ãããžã³ïŒããã©ã©ãžã³ïŒ
ãã©ãŸãžã³ïŒãšããšããªã³ïŒãµã«ãã¿ã¢ãŒã«ïŒã
ã«ãã¿ãªã³ïŒã¡ãã¯ããã©ããïŒçã ã 䜿çšäŸ ïŒ æ¬çºæã€ãªã³ãããªã¬ãŒãŒçšããã€ã¹ã®é¢å°å
åã³äžé¢å°åã®å®æœäŸåã³äœ¿çšäŸããã詳现ã«èª¬
æããã°äžèšã®éãã§ããã ããªãã¡ãäž¡å°åã®å°é»æ§ã²ã«å±€ã¯ååºã«ãŒã
ããŒã«R 491 20ééïŒ ïŒèžçæ°Ž30ééïŒ åã³ã°
ãªã»ãªã³40ééïŒ ããæãåã1.5mmãé¢ç©48cm2
ã®ç²åŒŸæ§ã²ã«ã§ãããé¢å°åã®ã€ãªã³æ§è¬å€å«æ
å°é»æ§ã²ã«å±€ã¯ããã«æŽã«ïŒééïŒ ãµãªãã«é žã
ããªãŠã ãæ·»å ãããäžé¢å°åã®å°é»æ§ã²ã«å±€ã«
ã¯ïŒééïŒ çšåºŠã®å¡©åãããªãŠã ãæ·»å ãããŠã
ãã ããã6Vé»æºã«æ¥ç¶ããã10KHzã®æ²»çãã«
ã¹ïŒããŠãŒãã€æ¯30ïŒ ïŒãåºåãããã¯ãŒãµãã©
ã€ãäžäœçã«ç©å±€ã貌ç䜿çšãããã å°ããã®äœ¿çšäŸã«æŒãããã©ã¹ã¿ãŒæ§é äœã¯é®
çã»æ¶çå€ãšããŠäœ¿çšããããã®ã§ãããããã®
å Žåãç®èåºæ¿æ§ã®ãªãç¯å²å ã§ã®ãã€ã¢ã¹é»å§
ã®åæå°å åã¯è±å極åŸã®åæ§ã®ç¯å²å ã§ã®äžå®
çšåºŠã®æ®åå極é»å§ã®æ®åç¶æã¯è¡ç®¡æ¡åŒµäœçšã
瀺ãæè¬å¹³æµçæ³ïŒGalvanizationïŒã䜵ããªã
ããããšã«ãªãã®ã§ãç¥çµçãé¢ç¯çããªãŠãã
æ§é¢ç¯ççã®çŸæ£ã«å¯ŸããŠçžä¹çèå¹ã瀺ããã®
ã§ããããšãç解ããããã 䜿çšäŸ ïŒ ïŒ ã¡ãããããŒã«ïŒæäžæŽèå€ïŒ 10ïŒ ã¡ãããããŒã«ïŒããã»ã¬ã€ã®ã€ç€ŸïŒã
å«æããäžèšç¬¬ïŒè¡šã«ç€ºãçµæã®é»æ¥µã·ãŒã
ïŒåé»æ¥µå ±åãïŒmmïŒé¢ç©50cm2ïŒãïŒïŒå¹Žä»€
31æïŒäœé75Kgåã³ïŒïŒå¹Žä»€39æïŒäœé56Kg
ã®å¥åžžç·æ§è¢«éšè åã ã®å·Šã®åè ã«é¢å°ååã³
äžé¢å°ååïŒæãçžäºã®ééãä¹±ïŒcmãããŠè²Œ
çåºå®ãã50KHzãããŠãŒãã€æ¯20ïŒ ïŒãã«ã¹
å¹ 4ÎŒsïŒãé»å§10ã®æ¡ä»¶äžãæ¬çºæè±å極
æ¹åŒã§ã€ãªã³ãããªã¬ãŒãŒæœçããïŒå¹³åãã«
ã¹é»æµïŒ50ïœïŒ¡ïŒãéé»åŸãOhrïŒ4hrïŒ8hrã®
æç¹ã§å³è éèãããããªã³åŠçããããŠãŒã
ã§20mlãã€æ¡è¡ããããããµã³ãã«ãšããã è¡ãããç»åäžã®ãã¡ããããŒã«æ¿åºŠã¯
Degenåã³RiessïŒJ.Chromat.121ïŒ72â75
ïŒ1976ïŒïŒã®æ°æ¶²ã¯ãããã°ã©ãæ³ã«åŸããã€ãª
ã³åæ€åºè£ 眮ãåããæ¥ç«ã¢ãã«163ãçšããŠã
ã€ã³ãžãšã¯ã·ãšã³ã«æŒããŠã¯220âïŒãªãŒãã³
ã§ã¯200âã®æž©åºŠæ¡ä»¶ã§æž¬å®ãããã«ã©ã ã¯ïŒ
ïŒ ã·ãªã³ã³ãå å¡«ããQFâïŒã¬ã©ã¹è£œã«ã©ã
ïŒïŒïœïŒãçšããã 枬å®çµæã第ïŒè¡šã«ç€ºãã å°ãäžèšæœçã«æŒããŠãçºèµ€çã®ç®èåºæ¿ã¯
çç¡ã§ãã€ãã
ãã ã€ãªã³æ§è¬å€ã®çµç®åžåãä¿é²ããå¹æçãªå±
ææè¬æ¹æ³ãšããŠãã€ãªã³ãããªã¬ãŒãŒã¯è¿æ
çã 泚ç®ããã€ã€ããïŒGlass JM et al.ïŒInt.J.
Dermatol.19 519ïŒ1980ïŒïŒRusso J.ïŒAm.J.
Hosp.Pharm.37 843ïŒ1980ïŒGangarosa LP et
al.ïŒJ.Pharmacol.Exp.Ther.212 377ïŒ1980ïŒïŒ
Kwon BS et al.ïŒJ.Infect.Dis.140 1014
ïŒ1979ïŒïŒHill JM et al.ïŒAnn.NY.Acad.Sci.284
604ïŒ1977ïŒåã³Tannebaum M.Phys.Ther.60
792ïŒ1980ïŒãçã ïŒã ãããå è¡æè¡ã«æŒããã€ãªã³ãããªã¬ãŒãŒ
ã¯ãéåžžãæç¶å¹³æµçºçè£ çœ®åã¯æç¶å¹³æµçºçè£
眮ã®åºå端åãšãè¬æ¶²å«æµžè±è綿çã§éå±æ¿çã®
å°äœã被èŠããŠæãé¢å°ååã³é¡äŒŒæ§æã®äžé¢å°
åãšãé£ç¶ããŠãªããããã®ã§ãããããã®å®æœ
ã¯ããªãç ©éã§ãããæè¬æ¹æ³ãšããŠæ¥µããŠæå¹
ãªãã®ã§ããã«ãæããããã®æ®åã¯éå®ããã
ããåŸãªããã®ã§ãã€ãããŸãããã®ã€ãªã³ãã
ãªã¬ãŒãŒã¯æäžããè¬å€ã®æ¥µæ§ãšåäžã®æ¥µæ§ãæ
ã€æç¶å¹³æµãŸãã¯æç¶å¹³æµãå©çšããŠäœ¿çšããã
ã®ã§ããããç®èã¯ç¬¬ïŒå³ã®ç®èç䟡åè·¯å³ã«ç€º
ãããã«ããªãŒã æµæRdcãšãå極æµæRpolãš
å極容éCpolãšããæãå極ã€ã³ããŒãã³ã¹ïŒº
ãšãæããŠããããã®ãªãŒã æµæRdcãå°ãé»æµ
è·¯ãšããäŸãã°æç¶å¹³æµçã®éåžžã®ã€ãªã³ãããª
ã¬ãŒãŒã«ãããŠã¯Rdcã極ããŠé«æµæã§ãããã
æ²»çã«å¿ èŠãªéã®è¬å€ãæäžããã«ã¯ãé«é»å§ã
ç®èã«å°å ããªããã°ãªããããã®ããç®èã«å¯Ÿ
ããåºæ¿ã匷ããããã©ïŒçºèµ€çãåŒèµ·ããæã
ããã€ããããã«ãç®èã®æå·é²æ¢ãèæ ®ããäœ
é»å§ã§è¡ãªããšå¿ èŠéã®æäžã¯æ¥µããŠå°é£ãªãã®
ã§ãã€ãã ãŸããåèšç®èã®ãªãŒã æµæRdcã¯é»æºã®åš
æ³¢æ°ã«äŸåããªã10KΩã»cmã1MΩã»cmçšåºŠã®
åçŽæµæã§ããããå極ã€ã³ããŒãã³ã¹ïŒºã¯äœ¿çš
ããé»å§ã®åšæ³¢æ°ãäŸãã°10KHz以äžã®å Žåå®è³ª
çã«ãŒãã«åæããããšãç¥ãããŠããã
ïŒYamamotoïŒet al.ïŒMed.ïŒ Biol.Eng.ïŒ
Comput.ïŒïŒ1978ïŒ16.592â594ïŒå±±æ¬ãïŒïŒå»çš
é»åãšçäœå·¥åŠïŒæå48幎ïŒç¬¬11巻第ïŒå·337â
342.ïŒ åŸã€ãŠé«ãåšæ³¢æ°ã®é»å§ã人äœã«å°å ãããšå
極ã€ã³ããŒãã³ã¹ïŒºã¯äœäžããããäœé»å§ã§ã®ã€
ãªã³ãããªã¬ãŒãŒãå¯èœãšãªããã®ã§ããããç®
èã®å極ã€ã³ããŒãã³ã¹ïŒºã¯ç¬¬ïŒå³ã®ç®èç䟡
åè·¯å³ã«ç€ºãããã«å極æµæRpolãšå極容é
Cpolãšã®äžŠååè·¯ã§è¡šããããããã第ïŒå³ïœ
ã«ç€ºããããªçŽæµãã«ã¹ãåã«å°å ããŠããå極
容éCpolã¯å é»ïŒæŸé»ãç¹°è¿ãããã«ã¹åºåã®
äŒæ¢æã«ãå é»ãããæ®åé»è·ïŒå極ïŒãå極æµ
æRpolãä»ããŠæ¥µããŠç·©æ ¢ã«æŸé»ïŒè±å極ïŒã
ãããã第ïŒå³ïœã«ç€ºãããã«è¬å€å°å ¥ã«ä¿ãã
é»æµã¯å®è³ªçã«æç¶å¹³æµã䜿çšããå Žåãšå€ãã
ç¡ããã®ãšãªããåšæ³¢æ°ã®é«ãçŽæµãã«ã¹ãåã«
å°å ããŠãç®èã€ã³ããŒãã³ã¹ã®äœäžã¯èµ·ããåŸ
ãªããã®ã§ãã€ãã ãŸãã第ïŒå³ïœã«ç€ºãããã«çŽæµãã«ã¹ã®åºå
æéãçãããå極容éCpolã«ããæ®åé»è·
ïŒå極ïŒãçããŠããé»æµå€ãå åäœããªããŸã§
ã®ãã«ã¹ã®äŒæ¢æéã®ééãåºããããšã«ããã
ããªãã¡ããŠãŒãã€æ¯ãå°ããããããšã«ããç®
èã€ã³ããŒãã³ã¹ïŒºãäœãããããšãèãããã
ããæ®åé»æ¥µïŒå極ïŒã¯ç®èäžã«æ®åããé»è·ã§
ããè¬å€æäžã«ã¯é¢äžããªãããå°å ¥å¹çã®ç¹ã§
åé¡ãæãããã®ã§ãã€ãã æ¬çºæã¯ãäžèšæ¬ ç¹ã解æ¶ãããã®ã§ãç®èã€
ã³ããŒãã³ã¹ãå åã«äœäžããããšãã§ãããã
ã«ããäœé»å§ãé«é»æµã§ã®äœ¿çšãå¯èœã«ããæŽã«
ã¯é«é»å§å°å ã«æŒããŠãç®èã«å¯Ÿããåºæ¿ãå°ãª
ãããã©ãçºèµ€çã®æããç¡ãå®å šãªã€ãªã³ãã
ãªã¬ãŒãŒçšããã€ã¹ãæäŸããããšãç®çãšã
ãã ãŸããæ¬çºæã¯ãæ²»çãã«ã¹åºåæã«å極容é
ã«è²¯ããããæ®åé»è·ãæå¹ã«ååããããšã«ã
ãäœé»åæ¶è²»ã®ã€ãªã³ãããªã¬ãŒãŒçšããã€ã¹ã
æäŸããããšãç®çãšããã ããã«æ¬çºæã¯å°åœ¢è»œéã®ã€ãªã³ãããªã¬ãŒãŒ
çšããã€ã¹ãç¹ã«äººäœç®èã«çŽæ¥è²ŒçãåŸã極ã
ãŠæäœç°¡åäžã€è»œéæ§é ã®ã€ãªã³ãããªã¬ãŒãŒçš
ããã€ã¹ãæäŸããããšãç®çãšããã 以äžãæ¬çºæã®ç¬¬ïŒã®å®æœäŸãå³é¢ç¬¬ïŒå³ä¹è³
第ïŒå³ãåç §ããŠè©³çŽ°ã«èª¬æããã 第ïŒå³ã«ãããŠïŒã¯ãããã¯å³ã§ç€ºããã€ãªã³
ãããªã¬ãŒãŒçšããã€ã¹ã§ãããïŒã¯é»æºäŸãã°
ïŒïŒ»ïŒ¶ïŒœã®ä¹Ÿé»æ± ã§ãããïŒã¯ãã«ã¹çºæ¯æ©æ§ã§ã
第ïŒå³ïœã«ç€ºããããªäŸãã°50KHzçšåºŠã®çŽæµã
ã«ã¹ãçºæ¯ããããã®æ©æ§ã§ãããïŒã¯ã€ãªã³æ§
è¬å€ãå«æããé¢å°åã§ãïŒã¯äžé¢å°åã§ããã
ïŒã¯ãåèšé¢å°åïŒåã³äžé¢å°åïŒã«æ¥ç¶ããã
人äœã§ããã ïŒã¯æ®åé»è·ååçšãã€ãã·ã¿ã§ãé»æºïŒãšäžŠ
åã«æ¥ç¶ãããŠãããïŒã¯ã€ã³ãã¯ã¿ã§ãããã
ã®ã€ã³ãã¯ã¿ïŒã¯ã¹ã€ããæ©æ§ïŒã«æ¥ç¶ãããŠã
ãããã®ã¹ã€ããæ©æ§ïŒã¯ãåèšãã«ã¹çºæ¯æ©æ§
ïŒããåºåãããæ²»çãã«ã¹ïŒïŒïŒïŒïŒïŒâŠã®äŒ
æ¢ãšåæã«ã第ïŒå³ã«ç€ºãæ®åé»è·ãååããã
ãã®éåè·¯ããªãã¡ã€ã³ãã¯ã¿ïŒãäž¡å°åïŒïŒïŒ
ã«çŽåã«æ¥ç¶ãããéåè·¯ã圢æããããã«èšã
ããããã®ã§ããã«ã¹çºæ¯æ©æ§ïŒã«äžŠåã«æ¥ç¶ã
ããŠããã 次ã«ããã®ããæ§æãããæ¬çºæã€ãªã³ãããª
ã¬ãŒãŒçšããã€ã¹ã®äœ¿çšæ¹æ³åã³äœçšã説æã
ãããŸãã人äœïŒã«é¢å°åïŒåã³äžé¢å°åïŒã貌
çããããã®æäœã«ãã第ïŒå³ã«ç€ºãè¬å€å°å ¥å
è·¯ã圢æããããããªãã¡ããã«ã¹çºæ¯æ©æ§ïŒã¯
第ïŒå³ïœã«ç€ºããã«ã¹ïŒïŒãåºåããããã®ãã«
ã¹ïŒïŒã®åºåæéã®éã人äœïŒã®ç®èã®äž»ãš
ããŠå極ã€ã³ããŒãã³ã¹ïŒºã«é»æµã¯æµãïŒãã«ã¹
é»æµIaïŒïŒé¢å°åïŒã®ã€ãªã³æ§è¬å€ã¯äž»ãšããŠå
極æµæRpolãéããŠçµç®åžåãããããããŠæ²»
çãã«ã¹ïŒïŒãäŒæ¢ãããšåæã«ããªãã¡ãã«ã¹
çºæ¯æ©æ§ïŒãOFFã«ãªããšåæã«ã¹ã€ããæ©æ§
ïŒã¯ONãã第ïŒå³ã«ç€ºãæ®åé»è·åååè·¯ã圢
æãããããã®åè·¯ã«ãããæ²»çãã«ã¹ïŒïŒã®åº
åæã«äººäœïŒã®ç®èã®å極ã€ã³ããŒãã³ã¹ïŒºã®
å極容éCpolã«å é»ãããæ®åé»è·ã¯ãå極容
éCpolãšã€ã³ãã¯ã¿ïŒãšã®ïŒ¬âïŒ£å ±æ¯ã«ããã
æ®åé»è·ååçšãã€ãã·ã¿ïŒã«ååãããããã
ãŠãã®ååãããé»è·ã¯ã次ã®æ²»çãã«ã¹ïŒïŒã®
åºåæã«æŸé»ãããããŸãããã®äœçšã¯ãå極容
éCpolã«å é»ãããæ®åé»è·ïŒå極ïŒãæ²»çã
ã«ã¹ïŒïŒã®äŒæ¢æéã«æŸé»ïŒè±å極ïŒããããšã«
ãªãïŒè±å極é»æµIbïŒãäž¡å°åéã®é»äœã¯æå®å€
以äžã奜ãŸããã¯çã¬ãã«ã«ãªãã å°ãäžèšå®æœäŸã«ãããŠã¯ãè±å極ãããšãšã
ã«æ®åé»è·ãååããæ段ãšããŠïŒ¬âïŒ£å ±æ¯ãå©
çšãããã®ã«ã€ããŠèª¬æããããããã«éå®ãã
ããã®ã§ã¯ç¡ããåã«æ®åé»è·ååçšãã€ãã·ã¿
ãèšãããã®ã§ãã€ãŠãè¯ãããŸãâïŒ£å ±æ¯ã«
ããååããæ§æçãæ®åé»è·ãååã§ããæ§æ
ã§ããã°ãããªãæ段ã§ãã€ãŠãè¯ãã ããã«ãè¬å€å°å ¥å¹çãæ®æé»è·ååå¹çãè
æ ®ãããã©ã³ã¹ïŒãã€ãŒãžãã³ãåŒæå§åè·¯ïŒ
DCâDCã³ã³ããŒã¿çã®ãã«ã¹é»å§ãæå§ããã
ãã®æ©æ§ãèšãããã®ã§ãã€ãŠãè¯ãããŸãæ²»ç
ãã«ã¹ã®ç«äžãç«äžãæã«ã人äœã«å€§ããªããŒã¯
é»æµãæµãããããã®ããŒã¯é»æµãå¶éãããã
ã®åºåé»æµå¶éåè·¯ãèšãããã®ã§ãã€ãŠãè¯
ãã ããã«ãé»æºé»å§ã»ãã«ã¹å·Ÿåã³çºæ¯åšæ³¢æ°ã
å°å ¥ããè¬å€ã®ç¹æ§ãçšéã«å¿ãä»»æã«å€æŽãã
ãã®ã§ãã€ãŠãè¯ãããéåžžãããŠãŒãã€æ¯0.1
ã0.7ãåšæ³¢æ°1KHzã500KHzçšåºŠã®å€ãæ¡çšã
ãã奜ãŸããã¯ããŠãŒãã€æ¯0.1ã0.4ãåšæ³¢æ°5K
Hzã200KHzã奜é©ã«äœ¿çšããåŸãããŸãããã
ããå¯å€ããããã®æ©æ§ãèšãå人差ã«ãã埮調
æŽãå«ããã³ã³ãããŒã«ããªããªãŒãã§ãããã
ã«ãããã®ã§ãã€ãŠãè¯ãã ãŸããæ¬çºæã§èšãè±å極ã®çšåºŠã¯ãç®èã«å®
åžžçã«å°å ãããããšã«ãªãæ®åå極é»å§ãç®è
ã€ãªããŒã·ãšã³ïŒåºæ¿ïŒãçèµ·ããªãç¯å²å ã§ã
ãã°è¶³ãã䜿çšãã«ã¹é»å§çã®äœ¿çšè«žæ¡ä»¶ã«ãã€
ãŠé©å®æ±ºå®ããåŸããã®ã§ããããéåžžã奜ãŸã
ãã¯æ®åé»å§ïŒïŒ»ïŒ¶ïŒœä»¥å ããã奜ãŸããã¯1.5
以å ã§ããã ããããã«ã¹é»æµéã«å¯Ÿããè±å極é»æµéã®æ¯
ã§ç€ºãã°ãéåžžãè±å極é»æµéã¯ãã«ã¹é»æµéã®
çŽ50ïŒ ä»¥äžã奜ãŸããã¯60ïŒ ä»¥äžããã奜ãŸãã
70ïŒ ä»¥äžã§ããã ããã«ãä»ã®èŠ³ç¹ããããã°ãè±å極é»æµå€ã
å®è³ªçã«ãŒãã¬ãã«ã«è¿æ¥ããå®åžžå€ã«ãªãçšåºŠ
ã®ç¯å²ã奜ãŸããã ä»æ¹ãç®èã€ãªããŒã·ãšã³ïŒåºæ¿ïŒã®çèµ·ããª
ãç¯å²å ã§ããã°ããã«ã¹é»å§ãšåæã«äžå®ã®å®
åžžãã€ã¢ã¹é»å§çãæŽã«å°å ãããŠããŠãããã
ãšã¯æããã§ããããããªãã¡ããã«ã¹ã»ã€ãªã³
ãããªã¬ãŒãŒãšåŸ®åŒ±ãªå¹³æµã€ãªã³ãããªã¬ãŒãŒã¯
åèšç¯å²å ã§äœµçšããåŸãã ãŸããäžèšå®æœäŸã«ãããŠã¯ãç®èç䟡åè·¯ã®
äžè¬çäŸã«ã€ããŠèª¬æããããå°åã®é»æ°çç¹æ§
ãèæ ®ããå Žåãç¥åæ§ã®ããšãèšããã 以äžã®èª¬æã§æãããªããã«æ¬çºæã€ãªã³ãã
ãªã¬ãŒãŒçšããã€ã¹ã«ããã°ãæç¶å¹³æµãŸãã¯å
ãªãæç¶å¹³æµã䜿çšãããã®ã«æ¯èŒããŠãåãé»
æºé»å§ãå°å ããå Žåç¥10æ°åãæ°10åã®é»æµã
æµããããšã«ãªããæ°åãæ°10åã®ã€ãªã³æ§è¬å€
å°å ¥å¹æãåŸãããããŸããäœé»å§ã§å¿ èŠéã®è¬
å€æäžãã§ãããããæãã¯ãäŸãã°50ç
ã®é«é»å§å°å ã«ãããŠããç®èã«å¯Ÿããåºæ¿ãè
ãã匱ããããã©ãçºèµ€çã®æãããå°ãªããã
ãã«é·æéã®äœ¿çšã«ãé©ããã€ãªã³ãããªã¬ãŒãŒ
çšããã€ã¹ãåŸãããã ããã«ãç®èã®å極容éã«è²¯ããããæ®åé»è·
ã¯è¬å€å°å ¥ã«ã¯é¢äžããªãç¡é§ãªé»è·ã§ãããã
æ¬çºæã€ãªã³ãããªã¬ãŒãŒçšããã€ã¹ã«ããã°ã
æ®åé»è·ã極ããŠæå¹ã«ååãã次ã®æ²»çãã«ã¹
åºåæã«æŸé»ãããæ§æãšããããèããé»åæ¶
è²»ã軜æžãããå¹æãæããããŸãäœé»åæ¶è²»ã®
ãããæ¯èŒçå°å®¹éã§å°åã®é»æ± ã§æå®ã®è¬å€å°
å ¥ãã§ããããããã€ã¹èªäœã®å°å軜éåã«ã極
ããŠæå¹ãªãã®ãšãªãåŸãã å°ã以äžã¯å®çšäžã®èŠ³ç¹ããåšæçãã«ã¹ã«ã€
ããŠèª¬æããããæ¬è³ªçã«ã¯éåšæçãã«ã¹ã«ã
ã€ãŠãåçã®å¹æãåŸããããã®ã§ããããšåã³
ãã«ã¹æ³¢åœ¢çã¯ç©åœ¢æ³¢ã«éå®ãããéæã§ããã
ãšã¯åœç¶ã§ããã 次ã«æ¬çºæã€ãªã³ãããªã¬ãŒãŒçšããã€ã¹ã®å
æ§æèŠçŽ åã³å®æœåœ¢æ çã«ã€ããŠãã詳现ã«èª¬æ
ããã 第ïŒå³ã¯ãã«ã¹é»å§ãæå§ãããã©ã³ã¹ãèš
ãããã®ãã©ã³ã¹ã®ïŒæ¬¡åŽå·»ç·ãã€ã³ãã¯ã¿ãšã
ãŠå©çšãããã®ã€ã³ãã¯ã¿ãšè² è·å®¹éãšã®ïŒ¬â
å ±æ¯ã«ãããè² è·å®¹éã®æ®åé»è·ãè±å極ãããš
ãšãã«ååããããã«ããåè·¯ã®äžå®æœäŸã§ã
ããå³ã«ãããŠãïŒã¯é»æºã§ãããã€ã¹ïŒå šäœã
å°å軜éåããããã«äŸãã°ãã¿ã³ç¶ã«åœ¢æãã
ãïŒïŒ»ïŒ¶ïŒœã®ãªããŠã é»æ± ã䜿çšããŠããããã®
é»æºïŒã¯ãã«ã¹çºæ¯æ©æ§ïŒã«æ¥ç¶ãããŠãããã
ã®ãã«ã¹çºæ¯æ©æ§ïŒã¯äŸãã°éå®å®ãã«ããã€ã
ã¬ãŒã¿åè·¯ã§åœ¢æãããŠãããåšæ³¢æ°50KHzïŒã
ãŠãŒãã€æ¯0.2ã®ãã«ã¹ãåºåããããã«æ§æã
ããŠãããïŒïŒã¯ãã©ã³ã¹ã§ããããã®ãã©ã³ã¹
ïŒïŒã¯ãã«ã¹é»å§ãæå§ããããã«èšããããã
ã®ã§äŸãã°å·»ç·æ¯ãïŒïŒïŒã«æ§æãããŠããããŸ
ãããã®ãã©ã³ã¹ïŒïŒã®ïŒæ¬¡åŽã¯ïŒ¬âïŒ£å ±æ¯çšã®
ã€ã³ãã¯ã¿ïŒãšããŠäœçšããããã«æ§æãããŠã
ããïŒã¯ã¹ã€ããã³ã°ãã©ã³ãžã¹ã¿ã§ããããã®
ã¹ã€ããã³ã°ãã©ã³ãžã¹ã¿ïŒã¯ãåèšãã«ã¹çºæ¯
æ©æ§ïŒããã®ãã«ã¹åºåã«ããåèšãã©ã³ã¹ïŒïŒ
ã®ïŒæ¬¡åŽãONâOFFããããã«èšãããããã®
ã§ãããïŒïŒã¯åè·¯ä¿è·çšã®ãã€ãªãŒãã§ããã
ïŒã¯æ®åé»è·ååçšã®ãã€ãã·ã¿ããªãã¡ã³ã³ã
ã³ãµã§ãããïŒïŒïŒã¯é¢å°ååã³äžé¢å°åã§äººäœ
ïŒã«æ¥ç¶ãããŠãããæ¬å®æœäŸã®äœçšåã³å¹æã¯
äžèšå®æœäŸãšåäžã®ãããã®èª¬æãçç¥ããã 次ã«ç¬¬ïŒå³ãåç §ããŠæ¬çºæã€ãªã³ãããªã¬ãŒ
ãŒçšããã€ã¹ã®åè·¯ã®ç¬¬ïŒã®å®æœäŸã詳现ã«èª¬æ
ãããåèšç¬¬ïŒã®å®æœäŸãšåäžéšåã«ã¯åäžç¬Šå·
ãä»ããŠãã®èª¬æãçç¥ããã æ¬å®æœäŸã¯èªå°é»æµãèªèµ·ããããã®ãã©ã³ã¹
ãèšãããã®ãã©ã³ã¹ã®äœçšã«ããè² è·å®¹éã®æ®
åé»è·ãè±å極ãããšãšãã«ååããããã«ãã
åè·¯ã§ãããå³ã«ãããŠïŒïŒã¯èªå°é»æµèªèµ·ãã©
ã³ã¹ã§ããããã®ãã©ã³ã¹ïŒïŒã¯ïŒæ¬¡åŽã®äž¡å°å
ïŒïŒïŒéã«çŽåã«æ¥ç¶ãããïŒæ¬¡åŽïŒïŒã¯ãéé»
æµé²æ¢çšã®ãã€ãªãŒãïŒïŒãä»ããŠïŒæ¬¡é»æ± ïŒïŒ
ã«æ¥ç¶ãããŠãããïŒã¯ãã«ã¹çºæ¯æ©æ§ã§ãåèš
ïŒæ¬¡é»æ± ïŒïŒã«æ¥ç¶ããããšãšãã«ç¬¬ïŒåã³ç¬¬ïŒ
ã®FETïŒïŒïŒïŒïŒã®ã²ãŒãã«æ¥ç¶ãããŠããã 次ã«æ¬å®æœäŸã®äœçšã説æããããŸãããã«ã¹
çºæ¯æ©æ§ïŒã¯ïŒæ¬¡é»æ± ïŒïŒãé»æºãšããŠç¬¬ïŒå³ã«
瀺ããããªãã«ã¹ïŒïŒãçºçããããã®ãã«ã¹ïŒ
ïŒã®ç«äžããšåæã«FETïŒïŒã®ãã¬ã€ã³âãœãŒ
ã¹éã¯å°éãããåŸã€ãŠããã«ã¹ïŒïŒã®åºåæé
ã®éã人äœïŒã®ç®èã®äž»ãšããŠå極ã€ã³ããŒ
ãã³ã¹ïŒºã«é»æµã¯æµãïŒãã«ã¹ã¹é»æµIaïŒïŒé¢å°
åïŒã®ã€ãªã³æ§è¬å€ã¯äž»ãšããŠå極æµæRpolã
éããŠçµç®åžåãããããããŠãã«ã¹ïŒïŒãäŒæ¢
ãããšåæã«FETïŒïŒã¯OFFãšãªããFETïŒïŒ
ã¯å°éãããåŸã€ãŠãå極ã€ã³ããŒãã³ã¹ïŒºã®å
極容éCpolã«å é»ãããæ®åé»è·ã¯ãèªå°é»æµ
èªèµ·ãã©ã³ã¹ïŒïŒã®ïŒæ¬¡åŽïŒïŒãå«ãéåè·¯ã«ã
ãç¬æã«è±å極ããããåæã«ãã©ã³ã¹ïŒïŒã«ã
ãïŒæ¬¡åŽïŒïŒã«ã¯èªå°é»æµãèªèµ·ãããããã®èª
å°é»æµã¯ãã€ãªãŒãïŒïŒãä»ããŠïŒæ¬¡é»æ± ïŒïŒã®
å¹çè¯ãååãããã å°ãäžèšå®æœäŸã«ãããŠã¯æ®åé»è·ãïŒæ¬¡é»æ±
ã«ååãããã®ã«ã€ããŠèª¬æããããã³ã³ãã³ãµ
ã«ååãããããããã®ã§ãã€ãŠãè¯ãããŸãèª
å°é»æµèªèµ·å¹çãïŒæ¬¡é»æ± ãŸãã¯ã³ã³ãã³ãµãžã®
å é»å¹çãèæ ®ãããã©ã³ã¹ã®å·»ç·æ¯ãé©å®å€æ
ãããã®ã§ãã€ãŠãè¯ãã 次ã«æ¬çºæã€ãªã³ãããªã¬ãŒãŒçšããã€ã¹ã®å š
äœæ§æã®å®æœäŸã以äžã«è©³è¿°ããã 第ïŒå³åã³ç¬¬ïŒïŒå³ã¯ç¬¬ïŒã®å®æœäŸã瀺ããå³
ã«ãããŠïŒïŒã¯ç®èäžäœè²Œçåããªãã¡ãã©ã¹ã¿
ãŒåœ¢ç¶ã«æ§æããã€ãªã³ãããªã¬ãŒãŒçšããã€ã¹
ã§ãé¢å°åïŒïŒãšäžé¢å°åïŒïŒãšãæããŠããã
åèšé¢å°åïŒïŒã¯ãæè»ã·ãŒãä¹è³ãã€ã«ã ç¶ã«
圢æããã€ãªã³æ§è¬å€å«æå°é»æ§ã²ã«å±€ïŒïŒãšã
ã¢ã«ãããŠã ç®çã®éå±ç®ïŒå°é»æ§ãŽã ä¹è³æš¹è
ãã€ã«ã ãŸãã¯ã«ãŒãã³ãã€ã«ã ãå°é»å¡æçã§
圢æãããé»æµåæ£çšå°é»æ§éšæå±€ïŒïŒãšãç©å±€
ããŠäžäœçã«åœ¢æãããã®ã§ããããŸããäžé¢å°
åïŒïŒã¯æè»ã·ãŒãä¹è³ãã€ã«ã ç¶ã«åœ¢æããã
å°é»æ§ã²ã«å±€ïŒïŒãšãåèšãšåæ§ã¢ã«ãããŠã ç®
çã§åœ¢æãããé»æµåæ£çšå°é»æ§éšæå±€ïŒïŒãšã
ç©å±€ããŠäžäœçã«åœ¢æãããã®ã§ãããåèšé¢å°
åïŒïŒã®äžé¢ç¥äžå€®éšã«ã¯ãã¯ãŒãµãã©ã€ãŠãã
ãïŒïŒãèšçœ®ãããŠããããã®ãã¯ãŒãµãã©ã€ãŠ
ãããïŒïŒã«ã¯ãé»æºäŸãã°ãããããã¿ã³ç¶é»
æ± ãšããã«ã¹çºæ¯æ©æ§ãšããã®ãã«ã¹çºæ¯æ©æ§ã®
æ²»çãã«ã¹äŒæ¢æã«åèšäž¡å°åïŒïŒïŒïŒïŒã®é»äœ
ãçã¬ãã«ã«ããããã®æ段åã³æ®åé»è·ãåå
ããããã®æ段ãšãå èšãããŠããããã®äžæ¹ã®
åºå端åäŸãã°ïŒâïŒç«¯åãé»æµåæ£çšå°é»æ§éš
æå±€ïŒïŒã«æ¥è§Šããããã«èšçœ®ãããŠããããŸã
ãã®ãã¯ãŒãµãã©ã€ãŠãããïŒïŒã®ïŒïŒïŒç«¯åã¯
ãã®äž¡ç«¯è¿åãé€ãäžé¢ã«çµ¶çžã³ãŒãã€ã³ã°ãæœ
ããäŸãã°ã¢ã«ãããŠã ç®ã®ãªãŒãç·ïŒïŒã«ãã
åèšäžé¢å°åïŒïŒã®é»æµåæ£çšå°é»æ§éšæå±€ïŒïŒ
ã«æ¥ç¶ãããŠãããïŒïŒã¯çµ¶çžæ§ãããã³ã°å±€ã§
ããããã®çµ¶çžæ§ãã«ãã³ã°å±€ïŒïŒã¯äŸãã°éå°
é»æ§ã®åææš¹èãæè»ã·ãŒãä¹è³ãã€ã«ã ç¶ã«åœ¢
æãããã®ã§ãåèšé¢å°åïŒïŒåã³äžé¢å°åïŒïŒ
ã¯ãã®çµ¶çžæ§ãããã³ã°å±€ïŒïŒã«é¢éããŠé 眮åº
çãããŠãããããªãã¡ãé¢å°åïŒïŒïŒäžé¢å°å
ïŒïŒåã³ãã¯ãŒãµãã©ã€ãŠãããïŒïŒã¯çµ¶çžæ§ã
ããã³ã°å±€ïŒïŒã«ããäžäœçã«æ¯æé£çµãããŠã
ãã 次ã«ãã®ããã«æ§æããã€ãªã³ãããªã¬ãŒãŒçš
ããã€ã¹ã®äœçšåã³äœ¿çšæ³ã説æããããŸã人äœ
ã®æ²»çåžæäœçœ®ã«é¢å°åïŒïŒãåœæ¥ããããã«è²Œ
çããããããšåæã«é¢å°åïŒïŒãšäžé¢å°åïŒïŒ
ãšã¯éåè·¯ã圢æãããã«ã¹çºæ¯ãéå§ãããŠé¢
å°åïŒïŒã®ã€ãªã³æ§è¬å€å«æå°é»æ§ã²ã«å±€ïŒïŒäž
ã®ã€ãªã³æ§è¬å€ã®çµç®æµžéã¯å éãããã æ¬å®æœäŸã«ãããšã人äœç®èã«çŽæ¥è²ŒçãåŸã
極ããŠæäœç°¡åäžã€è»œéã§ãå åãªè¬å€æäžå¹æ
ã®åŸãããã€ãªã³ãããªã¬ãŒãŒçšããã€ã¹ãåŸã
ããã 次ã«ç¬¬ïŒïŒå³åã³ç¬¬ïŒïŒå³ãåç §ããŠæ¬çºæã€
ãªã³ãããªã¬ãŒãŒçšããã€ã¹ããç®èäžäœè²Œçå
ããªãã¡ãã©ã¹ã¿ãŒåœ¢ç¶ã«æ§æãã第ïŒã®å®æœäŸ
ã«ã€ããŠè©³çŽ°ã«èª¬æãããå³ã«ãããŠïŒïŒã¯ã€ãª
ã³ãããªã¬ãŒãŒçšããã€ã¹ã§ãïŒïŒã¯é¢å°åãïŒ
ïŒã¯äžé¢å°åã瀺ãããã®é¢å°åïŒïŒåã³äžé¢å°
åïŒïŒã®é»æµåæ£çšå°é»æ§éšæå±€ïŒïŒïŒïŒïŒã¯ïŒ
mmçšåºŠé¢éããŠé 眮ãããŠããããã®äžé¢ã«ã¯äŸ
ãã°0.3mmçšåºŠã®æ¥µèã«åœ¢æãããã€ãªã³æ§è¬å€
å«æå°é»æ§ã²ã«å±€ïŒïŒãäžäœã«è²ŒçãããŠããã
ãŸããäžé¢å°åïŒïŒåã³é¢å°åïŒïŒã¯çµ¶çžæ§ãã
ãã³ã°å±€ïŒïŒã«ããäžäœçã«æ¯æé£çµãããŠã
ããïŒïŒåã³ïŒïŒã¯åã é¢å°åïŒïŒïŒäžé¢å°åïŒ
ïŒã«æ¥ç¶ããã端åã§ããããã®ç«¯åïŒïŒïŒïŒïŒ
ã®é éšã¯åèšçµ¶çžæ§ãããã³ã°å±€ïŒïŒã貫éããŠ
çªåºããŠããããã¯ãŒãµãã©ã€ãŠãããïŒïŒã¯ã
ã®ç«¯åïŒïŒïŒïŒïŒã«ããé»æ°çã«æ¥ç¶ããããšãš
ãã«æ©æ¢°çã«æ¯æé£çµãããã æ¬å®æœäŸã®ã€ãªã³ãããªã¬ãŒãŒçšããã€ã¹ã®äœ¿
çšæ¹æ³ã¯åèšç¬¬ïŒã®å®æœäŸãšåäžã®ããçç¥ã
ããæ¬å®æœäŸã«ãããšé¢å°åïŒïŒåã³äžé¢å°åïŒ
ïŒã«ç©å±€é 眮ããå°é»æ§ã²ã«å±€ãåäžããªãã¡äž
æã®ã€ãªã³æ§è¬å€å«æå°é»æ§ã²ã«å±€ïŒïŒãåé»æµ
åæ£çšå°é»æ§éšæå±€ïŒïŒïŒïŒïŒã«è²Œçããæ§æãš
ãããããåå°åéã«è¥å¹²ã®ãªãŒã¯é»æµãçãã
ããå°é»æ§ã²ã«å±€èªäœãæµæãæããŠããå°é»æ§
éšæå±€ïŒïŒïŒïŒïŒéã®è·é¢ãå°é»æ§ã²ã«å±€ïŒïŒã®
åãã«å¯ŸããŠæ¥µããŠå€§ããããã€ãªã³æ§è¬å€ã®ç®
è浞éå¹æã«ã¯ã»ãšãã©åœ±é¿ãçããªãã æ¬å®æœäŸã«ãããšãåèšç¬¬ïŒã®å®æœäŸã®å¹æã®
ä»ã«ãã®è£œé å·¥çšã極ããŠç°¡æäžã€èœççã«ãªã
å¹æãæãããããªãã¡ãå°é»æ§ã²ã«å±€ïŒå°é»æ§
éšæå±€ïŒçµ¶çžæ§ãããã³ã°å±€ãç©å±€é 眮ããäžæ¬
ã®åž¯ç¶ã·ãŒããæå®ã®ééããã€ãŠåæãããã®
ã«ç«¯ååã³ãã¯ãŒãµãã©ã€ãåä»ããã®ã¿ã§ãã
ã€ã¹ãåŸãã倧éçç£ãèæ ®ããå Žåã«ãããŠé
åžžã«æçšãªå¹æãå¥ãããããã«å®æœäŸã®ããã«
䞡端åã®é 眮ééãçããããã€ã¹äžé¢ã®ç¥äžå€®
éšã«ãã¯ãŒãµãã©ã€ãé 眮ãããšãããã€ã¹å šäœ
ã«å¯Ÿãããã¯ãŒãµãã©ã€ã®å€§ããã®åœ±é¿ã¯ã»ãšã
ã©ç¡ããã®ãšãªãã人äœã®æ²é¢éšã«è²Œçããå Žå
ã«ãããŠãæè»æ§ãã»ãšãã©æãªããã«è¯å¥œã«äœ¿
çšããããšãã§ããã 次ã«å³é¢ç¬¬ïŒïŒå³ãåç §ããŠæ¬çºæã€ãªã³ãã
ãªã¬ãŒãŒçšããã€ã¹ã®ç¬¬ïŒã®å®æœäŸã詳现ã«èª¬æ
ãããå³ã«ãããŠïŒïŒã¯ã€ãªã³ãããªã¬ãŒãŒçšã
ãã€ã¹ã§ãïŒïŒã¯äžé¢å°åã瀺ããïŒïŒã¯ãã¯ãŒ
ãµãã©ã€ã§ããã®ïŒâïŒç«¯åã¯é¢å°åïŒïŒã®é»æµ
åæ£çšå°é»æ§éšæå±€ïŒïŒã«æ¥ç¶ããããŸãïŒïŒïŒ
端åã¯ãªãŒãç·ïŒïŒãä»ããŠäžé¢å°åïŒïŒã®é»æµ
åæ£çšå°é»æ§éšæå±€ïŒïŒã«æ¥ç¶ãããŠããã æ¬å®æœäŸã®æ§æã«ãããšãé¢å°åãšäžé¢å°åãš
ã¯ãªãŒãç·ã®é·ãã®ç¯å²ã§ä»»æã«é¢ããŠäººäœã«è²Œ
çããããšãã§ãã貌çéšäœãå°ããå Žåãæ¯èŒ
ç倧ããªæ²çã®é¢ã«ãç¡çç¡ã䜿çšããããšãã§
ããããŸããé«æž©å€æ¹¿æã«äœ¿çšããç®èãå€éã«
çºæ±ããå Žåããåå°åã¯é¢ããŠããããè¡šç®ã
æµããé»æµã®åœ±é¿ãå šãåããªããã©ã¹ã¿ãŒæ§é
äœãåŸãããã 次ã«å³é¢ç¬¬ïŒïŒå³ãåç §ããŠæ¬çºæã€ãªã³ãã
ãªã¬ãŒãŒçšããã€ã¹ã®ç¬¬ïŒã®å®æœäŸã詳现ã«èª¬æ
ãããå³ã«ãããŠïŒïŒã¯ã€ãªã³ãããªã¬ãŒãŒçšã
ãã€ã¹ã§ãïŒïŒã¯ãã®é¢å°åãïŒïŒã¯äžé¢å°åã
瀺ãããã®äž¡å°åïŒïŒïŒïŒïŒã¯ãªãŒãç·ïŒïŒãä»
ããŠãã¯ãŒãµãã©ã€ïŒïŒã«æ¥ç¶ãããŠããããã®
ãã¯ãŒãµãã©ã€ïŒïŒã«ã¯é»æºäŸãã°åäžåœ¢ä¹Ÿé»æ±
ïŒæ¬ãšããã©ã³ã¹ãå©çšãããã«ã¹çºæ¯æ©æ§å
ã³ãæ²»çãã«ã¹ã®äŒæ¢æã«äž¡å°åïŒïŒïŒïŒïŒã®é»
äœãçã¬ãã«ã«ããããã®äŸãã°ã¹ã€ããæ©æ§ãš
æ®åé»è·ãååããããã®æ段ãšãå èšãããŠã
ããããã«ãã®ãã¯ãŒãµãã©ã€ïŒïŒã«ã¯åºåé»æµ
å¯å€åè·¯ãšã¿ã€ããŒåè·¯ãšãå èšãããŠããã æ¬å®æœäŸã«ãããšããã¯ãŒãµãã©ã€ãäž¡å°åãš
å¥äœã«ãããããåè·¯ã¹ããŒã¹çã«äœè£ãã§ã倧
容éã®ä¹Ÿé»æ± ã䜿ãããšãã§ããããŸãäž¡å°åã¯
åãªããã€ã«ã ç¶ã®è¶ 軜éã·ãŒããšãªããã人äœ
ãžã®è²Œçã極ããŠå®¹æã«ãªããããã«åºåé»æµå¯
å€åè·¯ãå èšããããã䜿çšè ã®ç®èæµæãå°å ¥
ããè¬å€ã®çš®é¡ãå¿ èŠéçã«ããä»»æã«åºåé»æµ
éãã³ã³ãããŒã«ããããšãã§ããããŸãã¿ã€ã
ãŒåè·¯ãèšãããããè¬å€ã®éå°æäžãé²ãããš
ãã§ããçã®å¹æãæããã å°ãäžèšå®æœäŸã«ãããŠã¯ãé¢å°åã«ã€ãªã³æ§
è¬å€ãå«æããå°é»æ§ã²ã«ã䜿çšãããã®ã«ã€ã
ãŠèª¬æããããããã«éå®ããããã®ã§ã¯ç¡ãã
åžæ°ŽçŽçã®çŽæãã¬ãŒãŒçã®åžæãè±è綿çã®ç¹
ç¶æãåææš¹èé£ç¶çºæ³¡äœãŸãã¯åžæ°Žæ§æš¹èçã®
ã¹ãã³ãžä¹è³å€å質æçã€ãªã³æ§è¬å€ä¹è³é»è§£è³ª
液ãå«æµžä¿æã§ãããã®ã§ããã°ãããªããã®ã§
ãã€ãŠãè¯ãããŸããå®æœäŸã«ãããŠã¯é¢å°åã®
å°é»æ§ã²ã«å±€ã«ãããããã€ãªã³æ§è¬å€ãå«æã
ããã®ã«ã€ããŠèª¬æããããã€ãªã³æ§è¬å€ã¯äœ¿çš
æã«å°åããã³ïŒãŸãã¯ç®èã«ä»äžããããã«ã
ããã®ã§ãã€ãŠãè¯ããããªãã¡ãå°é»æ§ã²ã«å±€
ã«ã¯ã€ãªã³æ§è¬å€ãå«æããŠããªããã®ã䜿çšã
æ²»çéå§æã«ã€ãªã³æ§è¬å€ãå«æããè»èãã¯ãª
ãŒã çãå°åããã³ïŒãŸãã¯ç®èã«å¡ä»ãç®è圢
æãããåŸãå°åã貌çãæ²»çãè¡ãªãããã«ã
ãã€ãªã³ãããªã¬ãŒãŒçšããã€ã¹ã§ãã€ãŠãè¯
ããããã«ãæå¹è¬å€ã€ãªã³çš®ã®é°éœã«å¿ããŠå°
åã®é°éœãèªåšã«å€æãåŸãã¹ã極æ§åææ段ã
åœè©²ããã€ã¹ã«ä»å ãããã®ã§ãã€ãŠãããã ãŸãããšãã«è¬å€æäžéã«å¿ããŠçäœã®ç¶æ³ã
å€åããå Žåããçäœã®ç¶æ³ã«å¿ããŠè¬å€æäžé
ãå¶åŸ¡ããªããŠã¯ãããªãå Žåã«ãããŠã¯ãåèš
çäœç¶æ³ãç£èŠããªããåºåé»æµãèªåçã«å¶åŸ¡
ããããã®ãã€ãŒãããã¯æ©æ§ãå èšããæ§æã«
ãããã®ã§ãã€ãŠãè¯ããäŸãã°ãç¹ã«ã€ã³ã·ãŠ
ãªã³ã®æäžã®ããã«ãè¡æ¶²äžã®è¡ç³å€ã«ããæäž
éãå¶åŸ¡ããå¿ èŠã®ããå Žåã«ã¯ãè¡ç³å€ãç£èŠ
ããã»ã³ãµãŒããã¯ãŒãµãã©ã€ã«æ¥ç¶ãããã®ã»
ã³ãµãŒã®æ€ç¥åºåã«ããèªåçã«åºåé»æµãã
ã³ïŒãŸãã¯åºåæéçãå¶åŸ¡ãããã€ãŒãããã¯
æ©æ§ãèšãããã®ã§ãã€ãŠãè¯ãããã®ããã«æ§
æããå Žåã¯åŸæ¥ã®æäžæ¹æ³ã§ã¯å°åºãªãåŸãªã
ã€ãçäœç¶æ³ã«å¿ããæé©ãªè¬å€æäžãè¡ãªãã
ãšãã§ããã æ¬äŸãã©ã¹ã¿ãŒæ§é äœã®åæ§æèŠçŽ çã«ä»ãæŽ
ã«è©³çŽ°ã«å説ããã°æ¬¡ã®éãã§ããã å°é»æ§ã²ã«å±€ ãã®å±€ã¯å¥œé©ã«ã¯ãã«ã©ã€ã¬ã ïŒãã©ã¬ã«ã³ã
ã¬ã ïŒã¶ã³ãµã³ã¬ã¹çã®å€©ç¶æš¹èå€ç³é¡åã¯ããª
ããã«ã¢ã«ã³ãŒã«éšåã±ã³åç©ïŒããªããã«ãã«
ããŒã«ïŒããªããã«ã¡ãã«ãšãŒãã«åã³ãã®ã³ãŒ
ããªãïŒããªããã«ãããªãã³ïŒããªããã«ã¡ã¿
ã¯ãªã¬ãŒãçã®ããã«ç³»æš¹èïŒããªã¢ã¯ãªã«é žå
ã³ãã®ãããªãŠã å¡©ïŒããªã¢ã¯ãªã«ã¢ããåã³ã
ã®éšåå æ°Žå解ç©ïŒããªã¢ã¯ãªã«é žãšã¹ãã«éšå
ã±ã³åç©ïŒããªïŒã¢ã¯ãªã«é žâã¢ã¯ãªã«ã¢ããïŒ
çã®ã¢ã¯ãªã«ç³»æš¹èãªã©ã芪氎æ§ãæããå皮倩
ç¶åã¯åææš¹èé¡ãæ°Žåã³ïŒåã¯ãšãã¬ã³ã°ãªã³
ãŒã«ïŒã°ãªã»ãªã³çã®ã¢ã«ã³ãŒã«é¡ã§æè»å¯å¡å
ããŠèªå·±ä¿åœ¢æ§ãç®èæ¥çæ§ãæããæè»ãã€ã«
ã ä¹è³ã·ãŒãç¶ã²ã«ãšããŠæäŸãããã ä»æ¹ãããã«å åãªå°é»æ§ãä»äžãã¹ãå¡©åã
ããªãŠã ïŒçé žãããªãŠã ïŒãããé žã«ãªãŠã
çã ã®é»è§£è³ªãæçšéïŒéåžžïŒã15ïŒ çšåºŠïŒæ·»å
ãããããã®ããã«ããŠåŸãããæ¬çºæã§å¥œé©ãª
å°é»æ§ã²ã«å±€ã¯ãæè»ãã€ã«ã ä¹è³ã·ãŒãç¶ã§ã
ã€ãŠç®èã«å¯çãåŸããã®ã§ãããããç®èæ¥è§Š
æµæãäœãè¬å€ã€ãªã³ã®çµç®æµžéã«å¹æçã§ãã
ã®ã¿ãªãããæ¥çããŒãçã®ä»ã®ç®èæ¥çæ段ã
èŠããæ§é äœå šäœãç®èã«è²Œçæ¯æãåŸããšãã
䜿çšäžã®å©ç¹ãã䜵ãæãããã®ã§ãããç¹ã«ã²
ã«å±€ã®åºæãšããŠåèšã«ã©ã€ã¬ã¹çã®å€©ç¶æš¹èå€
ç³é¡ã䜿çšããå Žåã¯ããã®å€©ç¶é«ååé žæ§é ã«
ããPHç·©è¡æ§ä¹è³ç®èä¿è·æ§ãèããé«ãä¿æ°Žèœ
åãé©åºŠãªç®èç²çæ§çã«ãããåã«é»æ°ååŠç
ã«è¯å¥œãªå°é»æ§ã²ã«ãæäŸãåŸãã®ã¿ãªãã奜é©
ãªç®èé©åæ§ãåŸããããã®ã§ããã åããããã²ã«å±€ã®çµæé åã«åœã€ãŠã¯ãæè¬
é»æ°æ³³åçšã²ã«ã®å Žåãšã»ãŒåæ§ã®é»æ°ååŠçé
æ ®ããªãããã¹ãããšã¯åœç¶ã§ããããäž»ãšããŠ
䜿çšè¬å€ã®çš®é¡ãšæèŠæäžéïŒçšéïŒã貌ç䜿çš
æéã䜿çšé»æ± ã®åºååã³ç®èæ¥è§Šé¢ç©çã ã«ã
ãããã®ã€ãªã³ã»ã¢ããªãã€ä¹è³é»å°åºŠãæèŠå€
ã«ãªãããé©å®å®æœããããã®ã§ããã ããã§ãæ¬äŸã«æŒãã奜é©ãªå°é»æ§ã²ã«å±€ã®ã¿
ãªãã幟ã€ããããå ·äœçã«ç€ºãã°äžèšã®éãã§
ããïŒ ïŒ åžžæ³ã«ãããå¹³åååé44äžãã±ã³å床çŽ60
ïŒ ã®ããªããã«ã¢ã«ã³ãŒã«ç²æ«30ïœã調補ãã
ããã«äºã80âã«å ç±ããã10ïŒ NaClå«æèž
çæ°Ž40ïœåã³ã°ãªã»ãªã³30ïœãæ·»å ãæ¹æãã
次ãã§åŸãããæ··åç©ã80âã«å ç±ããããã
ããã¬ã¹æ©ã«ããå§å0.6KgïŒcm2ã§çŽ20åéå
ç±å å§ããŠåãïŒmmã®æè»ã·ãŒãç¶ç©ãåŸãã
ãã®æè»ã·ãŒãç¶ç©ã¯å åãªç®èæ¥çæ§ãæã
äžã€ãã®çŽæµæ¯æµæïŒä»¥äžãåæ§ïŒã¯0.8K
Ωã»cmã§ãã€ãã ïŒ äžèšïŒãšåæ§ã«ããŠäžèšçµæã«ããæè»ã·ãŒ
ãç¶ã®å°é»æ§ã²ã«å±€ã補é ããã çµæäŸ ïŒ¡ ããªããã«ãããªãã³ïŒGAF瀟補PVPâ
K90ïŒå¹³åååé36äžïŒ âŠâŠ20ïœ 10ïŒ NaClå«æèžçæ°Ž âŠâŠ40ïœ ã°ãªã»ãªã³ âŠâŠ40ïœ åŸãããã·ãŒãã¯åŒ·ãç®èæ¥çæ§ãæãäž
ã€ãã®æ¯æµæã¯0.2KΩã»cmã§ãã€ãã çµæäŸ ïŒ¢ ããªããã«ãã«ããŒã«ïŒå¹³åååé160äžïŒ
ãã«ããŒã«å床15ïŒ ïŒåæããªããã«ã¢ã«ã³
ãŒã«ã®ã±ã³å床60ïŒ ïŒ âŠâŠ15ïœ ïŒïŒ NaClå«æèžçæ°Ž âŠâŠ70ïœ ãããã¬ã³ã°ãªã³ãŒã« âŠâŠ15ïœ åŸãããã·ãŒãã¯å åãªç®èæ¥çæ§ãæ
ãããã®æ¯æµæã¯1.0KΩã»cmã§ãã€ãã çµæäŸ ïŒ£ ããªããã«ã¢ã»ãã¢ã»ã¿ãŒã«ïŒå¹³åååé44
äžïŒã¢ã»ã¿ãŒã«å床30ïŒ ïŒåºçºããªããã«ã¢
ã«ã³ãŒã«ã®ã±ã³å床70ïŒ ïŒ âŠâŠ40ïœ 15ïŒ NaClå«æèžçæ°Ž âŠâŠ50ïœ ãšãã¬ã³ã°ãªã³ãŒã« âŠâŠ10ïœ å åãªç®èç²çæ§ãæããæ¯æµæ0.75K
Ωã»cmã ïŒ ããªã¢ã¯ãªã«é žãœãŒãïŒæ¥æ¬çŽè¬ç€Ÿè£œã¢ãã³
ãã¹SSïŒå¹³åååé300ã500äžïŒ20ïœãïŒïŒ
NaClå«æèžçæ°Ž12ïœåã³ã°ãªã»ãªã³æº¶æ¶²68ïœ
ãšåäžã«æ··åãã80âã§10åéå ç±å å§ããŠæ
è»ã·ãŒãç¶ç©ãåŸãããã®ã·ãŒãã¯é©åºŠã®ç®è
æ¥çæ§ãæãäžã€ãã®æ¯æµæã¯ïŒæŒå€æŸçœ®åŸã§
0.5KΩã»cmã§ãã€ãã ïŒ ã«ã©ã€ã¬ã¹30ïœãšïŒïŒ NaClå«æèžçæ°Ž30ïœ
åã³ã°ãªã»ãªã³40ïœãšãæ··åããå ç±å å§ããŠ
åæ§ã«ã·ãŒããäœæãããæ¯æµæ0.65KΩã»
cmã ïŒ ããªã¢ã¯ãªã«é žãœãŒãïŒæ¥æ¬çŽè¬ç€Ÿè£œã¢ãã³
ãã¹ïŒ³ïŒå¹³åååé300ã500äžïŒ20ïœãïŒïŒ
NaClå«æ粟補氎80ïœãšæ··åãå ç±å å§ããŠå
æ§ã«ã·ãŒããäœæãããæ¯æµæ0.47KΩã»cmã ãŸããç¹ã«é»æ°ååŠç芳ç¹ããããã°ããã©ã
ã©ãããŒã«ïŒã€ã³ã¹ãªã³ïŒãªãã«ã€ã³ïŒã·ã¹ãã€
ã³çã®å¡©åºæ§è¬å€ã¯ããªã¢ã¯ãªã«é žãã¡ãã«ãã
ã«ãšãŒãã«ã»ç¡æ°Žãã¬ã€ã³é žå ±éåäœïŒG.A.F.
瀟補GANTREZR ANâ169çïŒãã«ã«ããã·ã
ãªãšãã¬ã³ïŒGOODRICH瀟補CARBOPOLR
çïŒçã®é žæ§é«ååããåãã¢ã¹ã³ã«ãã³é žããµ
ãªãã«é žãäºç¡é žããªã³é žãªããã©ãã³ããªã³é ž
ãã¿ã¡ã¿ãŸã³ããã¬ããã€ã³ïŒtransâretinoic
acidïŒçã ã®é žæ§è¬å€ã¯ããªã¢ã¯ãªã«ã¢ããçã®
å¡©åºæ§é«ååãåã ã²ã«åºæãšããããšã«ããç®
çè¬å€ã®é«èœçã®ç§»åãéæãåŸãããšãç解ã
ãããã äŸãã°ãããã©ãããŒã«çšã²ã«çµæã®äžäŸã瀺
ãã°äžèšã®éãã§ããã ã«ãŒãããŒã«R 491åã¯GANTREZR ANâ
169 30éééš ã°ãªã»ãªã³ 45éééš æ°Ž 15éééš ãããã©ãããŒã« 10éééš æŽã«ããã®ã²ã«çµæç©ãåãçŽ0.1ã0.5mmçšåºŠ
ã®èªå·±æ¥çæ§ãã€ã«ã ãšãããã®ã¯ãåèšã®éã
é¢å°åã»äžé¢å°åäžäœåãã€ã«ã é»æ¥µãšããŠäœ¿çš
ã«æ¥µããŠå¥œé©ãšãªãã æŽã«åãããªããã«ã¢ã«ã³ãŒã«ãããªããã«ã
ããªãã³çã ã®éã€ãªã³æ§é«ååãåãé»æ°ååŠ
çã«æ¯èŒçé«å¹çã®ã²ã«ãæäŸãåŸããã®ã§ãã
ããšãç解ããããã äžèšããæãããªéããæ¬çºæå°é»æ§ã²ã«å±€ã®
ã²ã«åºæçµæä¹è³ç¯å²ã¯ç¹å®ã®ãã®ã«éå®ããã
ãã®ã§ã¯ãªãåºæ±ãªèŠªæ°Žæ§é«ååé¡ãæ°Žåã³ïŒå
ã¯ã¢ã«ã³ãŒã«é¡ã«ãŠæè»å¯å¡åããŠäœ¿çšã«äŸãã
ããã®ã§ããããéåžžãä¿åœ¢æ§ãæããããã«ã¯
芪氎æ§é«åå10ã70ééïŒ åã³æ®éšæ°Žåã³ïŒåã¯
ã¢ã«ã³ãŒã«ã®çµæç¯å²å ã§éžæå®æœããããäžèš
äŸç€ºã®åå°é»æ§ã²ã«å±€ã¯ããèªäœãå åãªç®èç²
çæ§ãæãããã®ã§ããããææã®å Žåãã¢ã¯ãª
ã«ç³»ç²çå€ãé ¢é žããã«ãšãã«ãžãšã³ç³»ç²çå€ç
ã®æå§æ§ç²çæåãæŽã«æ·»å ããŠãããã ãã®ããã«ãæ§é äœã®åšèŸºéšä¹è³ç«¯éšçã«ç®è
æ¥çæ§äžã€å°é»æ§ã®ã²ã«å±€ãé 眮ããããšã«ã
ããæ¥çããŒãçã®ä»ã®åºå®æ段ãäœãèŠããã«
åœè©²æ§é äœå šäœãç®èã«åºå®ä¿æãããã å°ãå°é»æ§ã²ã«å±€ãé¢å°åã®å€«ã§ããå Žåã¯ã
åæ²åã²ã«çµæäžãé»è§£è³ªæåãå³ã¡å¡©åãããª
ãŠã ã®ïŒéšåã¯å šéšã«ä»£ããŠæèŠã®ã€ãªã³æ§è¬å€
ãæ·»å 溶åããããã°è¶³ãããã®ã§ãããæèŠã®
å Žåãä¿æ°Žæ§éšæå±€ãçè±èªåšã«ããäºãè¬æ¶²å«
浞æžã®åœè©²éšæã䜿çšæã«æ§é äœæå®äœçœ®ã«é
眮ãæœè¡äœ¿çšããŠããããåãåžæ°Žæ§éšæã«ä»£ã
ãŠãå¯å€©ã²ã«ïŒãŒã©ãã³ã²ã«çã®é»æ°æ³³ååéã§
æ±çšã®éç²çæ§ãã€ããã²ã«ã䜿çšããŠãããã
ãšã¯æããã§ãããå¯å€©æ°Žã²ã«çµæã®ïŒäŸã瀺ã
ã°æ¬¡ã®éãã§ããã å¯å€©æ°Ž 4.0éééš ç²Ÿè£œæ°Ž 100.0 ã ãã¿ãã³ïŒ£ 5.0 ã ïŒã¢ã¹ã³ã«ãã³é žïŒãã®Naå¡©ãïŒïŒïŒïŒ ãã®çš®ã®ãã€ããã²ã«çã¯ãäºãæ§é äœã«ç©å±€
é 眮ãããŠããããæãã¯åè¿°ã®éã䜿çšæã«é
眮ãããããã«ããŠãããã å°ããã®ããã«å¯å€©ã²ã«çã®éç²çæ§ãã€ãã
ã²ã«ã䜿çšããå Žåã¯ãæ¬äŸã®æ§é äœå€å»¶éšåã«
æŽã«æ¥çããŒãçã®ç®èç²çæ§åºå®æ段ãä»»æã«
ä»å ããããã®ã§ããããšã¯åœç¶ã§ããã ã€ãªã³æ§è¬å€ ã€ãªã³è§£é¢æ§è¬å€ã§ããã°å šãŠäœ¿çšãåŸããã
ã€ãªã³ãããªã¬ãŒãŒåéã«æŒããŠæ¢ã«æ±çšãããŠ
ãããã®ã®ïŒéšãäŸç€ºããã°æ¬¡ã®éãã§ããïŒãš
ãŒãã«ãªïŒå¡©é žããã«ã€ã³ïŒã¡ãªã³ãŒã«ïŒãã¿ã
ã³B1ïŒB2ïŒB6ïŒïŒ£çã®åçš®ç®èãã¿ãã³ïŒãã¹
ã¿ãã³ïŒãµãªãã«é žãããªãŠã ïŒãããµã¡ã¿ãŸ
ã³ïŒãªã³é žãã¿ã¡ã¿ãŸã³ïŒãšããããšãªã³ïŒãã€
ããã³ã«ããªã³ïŒã€ãã¯ãœãªãžã³ïŒãããã©ãã
ãŒã«ïŒäºç¡é žå¡©ïŒãã¬ãªãã€ã·ã³ïŒãŠã³ãã·ã¬ã³
å¡©é žïŒãããµã¡ã¿ãŸã³ãªã³é žãšã¹ãã«ã®ãããªãŠ
ã å¡©ïŒãã¬ãããŸãã³ãªã³é žãããªãŠã ïŒã¢ãªã¡
ããžã³ïŒã¯ãã«ããšãã©ãã³ïŒã¯ã¬ãã¹ãã³ïŒãž
ãã³ã¯ã©ããïŒã³ã«ããã³ïŒãžã¯ãããšããã¯ïŒ
ã¯ãã«ããããžã³ïŒã¯ãã«ãžã¢ãŒããã·ãïŒã¯ã
ããŒãã ïŒããžãã©ãã³ïŒã€ãœãã©ãã³ïŒã¢ãã
ãã³ïŒãšã«ãŽã¿ãã³ïŒãããšãžãã³ïŒã¢ã«ãã¬ã
ããŒã«ïŒã€ã³ããããŒã«ïŒãªã¯ã¹ãã¬ãããŒã«ïŒ
ã€ãœãã¬ããªã³ïŒãããã©ãããŒã«ïŒãã¿ããž
ã³ïŒã¯ãããžã³ïŒã°ã¢ãããžã³ïŒããã©ã©ãžã³ïŒ
ãã©ãŸãžã³ïŒãšããšããªã³ïŒãµã«ãã¿ã¢ãŒã«ïŒã
ã«ãã¿ãªã³ïŒã¡ãã¯ããã©ããïŒçã ã 䜿çšäŸ ïŒ æ¬çºæã€ãªã³ãããªã¬ãŒãŒçšããã€ã¹ã®é¢å°å
åã³äžé¢å°åã®å®æœäŸåã³äœ¿çšäŸããã詳现ã«èª¬
æããã°äžèšã®éãã§ããã ããªãã¡ãäž¡å°åã®å°é»æ§ã²ã«å±€ã¯ååºã«ãŒã
ããŒã«R 491 20ééïŒ ïŒèžçæ°Ž30ééïŒ åã³ã°
ãªã»ãªã³40ééïŒ ããæãåã1.5mmãé¢ç©48cm2
ã®ç²åŒŸæ§ã²ã«ã§ãããé¢å°åã®ã€ãªã³æ§è¬å€å«æ
å°é»æ§ã²ã«å±€ã¯ããã«æŽã«ïŒééïŒ ãµãªãã«é žã
ããªãŠã ãæ·»å ãããäžé¢å°åã®å°é»æ§ã²ã«å±€ã«
ã¯ïŒééïŒ çšåºŠã®å¡©åãããªãŠã ãæ·»å ãããŠã
ãã ããã6Vé»æºã«æ¥ç¶ããã10KHzã®æ²»çãã«
ã¹ïŒããŠãŒãã€æ¯30ïŒ ïŒãåºåãããã¯ãŒãµãã©
ã€ãäžäœçã«ç©å±€ã貌ç䜿çšãããã å°ããã®äœ¿çšäŸã«æŒãããã©ã¹ã¿ãŒæ§é äœã¯é®
çã»æ¶çå€ãšããŠäœ¿çšããããã®ã§ãããããã®
å Žåãç®èåºæ¿æ§ã®ãªãç¯å²å ã§ã®ãã€ã¢ã¹é»å§
ã®åæå°å åã¯è±å極åŸã®åæ§ã®ç¯å²å ã§ã®äžå®
çšåºŠã®æ®åå極é»å§ã®æ®åç¶æã¯è¡ç®¡æ¡åŒµäœçšã
瀺ãæè¬å¹³æµçæ³ïŒGalvanizationïŒã䜵ããªã
ããããšã«ãªãã®ã§ãç¥çµçãé¢ç¯çããªãŠãã
æ§é¢ç¯ççã®çŸæ£ã«å¯ŸããŠçžä¹çèå¹ã瀺ããã®
ã§ããããšãç解ããããã 䜿çšäŸ ïŒ ïŒ ã¡ãããããŒã«ïŒæäžæŽèå€ïŒ 10ïŒ ã¡ãããããŒã«ïŒããã»ã¬ã€ã®ã€ç€ŸïŒã
å«æããäžèšç¬¬ïŒè¡šã«ç€ºãçµæã®é»æ¥µã·ãŒã
ïŒåé»æ¥µå ±åãïŒmmïŒé¢ç©50cm2ïŒãïŒïŒå¹Žä»€
31æïŒäœé75Kgåã³ïŒïŒå¹Žä»€39æïŒäœé56Kg
ã®å¥åžžç·æ§è¢«éšè åã ã®å·Šã®åè ã«é¢å°ååã³
äžé¢å°ååïŒæãçžäºã®ééãä¹±ïŒcmãããŠè²Œ
çåºå®ãã50KHzãããŠãŒãã€æ¯20ïŒ ïŒãã«ã¹
å¹ 4ÎŒsïŒãé»å§10ã®æ¡ä»¶äžãæ¬çºæè±å極
æ¹åŒã§ã€ãªã³ãããªã¬ãŒãŒæœçããïŒå¹³åãã«
ã¹é»æµïŒ50ïœïŒ¡ïŒãéé»åŸãOhrïŒ4hrïŒ8hrã®
æç¹ã§å³è éèãããããªã³åŠçããããŠãŒã
ã§20mlãã€æ¡è¡ããããããµã³ãã«ãšããã è¡ãããç»åäžã®ãã¡ããããŒã«æ¿åºŠã¯
Degenåã³RiessïŒJ.Chromat.121ïŒ72â75
ïŒ1976ïŒïŒã®æ°æ¶²ã¯ãããã°ã©ãæ³ã«åŸããã€ãª
ã³åæ€åºè£ 眮ãåããæ¥ç«ã¢ãã«163ãçšããŠã
ã€ã³ãžãšã¯ã·ãšã³ã«æŒããŠã¯220âïŒãªãŒãã³
ã§ã¯200âã®æž©åºŠæ¡ä»¶ã§æž¬å®ãããã«ã©ã ã¯ïŒ
ïŒ ã·ãªã³ã³ãå å¡«ããQFâïŒã¬ã©ã¹è£œã«ã©ã
ïŒïŒïœïŒãçšããã 枬å®çµæã第ïŒè¡šã«ç€ºãã å°ãäžèšæœçã«æŒããŠãçºèµ€çã®ç®èåºæ¿ã¯
çç¡ã§ãã€ãã
ãè¡šã
ãè¡šã
ïŒ ãžã¯ãããšããã¯ãããªãŠã ïŒæççå€ïŒ
ïŒïŒ
ãžã¯ãããšããã¯ãããªãŠã ïŒããã»ã¬
ã€ã®ã€ç€ŸïŒãå«æããäžèšç¬¬ïŒè¡šã«ç€ºãçµæã®
é»æ¥µã·ãŒãïŒåãïŒmmïŒé¢ç©50cm2ïŒã幎什35
æïŒäœé55Kgã®å¥åžžç·æ§è¢«éšè ã®å·Šã®åè ã«ïŒ
æãçžäºã®ééãçŽïŒcmãããŠè²Œçåºå®ããå
èšã¡ãããããŒã«ã«æŒãã䜿çšäŸãšåæ§ã®æ¡ä»¶
ã§éé»ããïŒæéåŸã«20mlæ¡è¡ããŠè¡æ¶²ã®åãµ
ã³ãã«ãåŸããã®è¡ãããç»åãæºåããã ãžã¯ãããšããã¯ãããªãŠã ã®è¡ãããç»å
äžã®æ¿åºŠã¯GeigerïŒDegenåã³SioufiïŒJ.
Chromat.111ïŒ293â298ïŒïŒ1976ïŒïŒã®æ¹æ³ãã
ããã«ä¿®æ£ããæ°â液ã¯ãããã°ã©ãæ³ã«ã
ããã€ãªã³åæ€åºè£ 眮ãåããæ¥ç«ã¢ãã«163
ãçšããŠåèšäŸãšåäžã®æž©åºŠæ¡ä»¶ã§æž¬å®ããã
ã«ã©ã ã¯ãïŒïŒ ã·ãªã³ã³ãå å¡«ããã¬ã©ã¹è£œ
QFâïŒã«ã©ã ïŒïŒïœïŒãçšããã ãã®çµæããžã¯ãããšããã¯ãããªãŠã ã®ïŒ
æéç®ã®è¡ãããã¬ãã«ã¯çŽ128nïœïŒmlã§ã
ã€ãã
ã€ã®ã€ç€ŸïŒãå«æããäžèšç¬¬ïŒè¡šã«ç€ºãçµæã®
é»æ¥µã·ãŒãïŒåãïŒmmïŒé¢ç©50cm2ïŒã幎什35
æïŒäœé55Kgã®å¥åžžç·æ§è¢«éšè ã®å·Šã®åè ã«ïŒ
æãçžäºã®ééãçŽïŒcmãããŠè²Œçåºå®ããå
èšã¡ãããããŒã«ã«æŒãã䜿çšäŸãšåæ§ã®æ¡ä»¶
ã§éé»ããïŒæéåŸã«20mlæ¡è¡ããŠè¡æ¶²ã®åãµ
ã³ãã«ãåŸããã®è¡ãããç»åãæºåããã ãžã¯ãããšããã¯ãããªãŠã ã®è¡ãããç»å
äžã®æ¿åºŠã¯GeigerïŒDegenåã³SioufiïŒJ.
Chromat.111ïŒ293â298ïŒïŒ1976ïŒïŒã®æ¹æ³ãã
ããã«ä¿®æ£ããæ°â液ã¯ãããã°ã©ãæ³ã«ã
ããã€ãªã³åæ€åºè£ 眮ãåããæ¥ç«ã¢ãã«163
ãçšããŠåèšäŸãšåäžã®æž©åºŠæ¡ä»¶ã§æž¬å®ããã
ã«ã©ã ã¯ãïŒïŒ ã·ãªã³ã³ãå å¡«ããã¬ã©ã¹è£œ
QFâïŒã«ã©ã ïŒïŒïœïŒãçšããã ãã®çµæããžã¯ãããšããã¯ãããªãŠã ã®ïŒ
æéç®ã®è¡ãããã¬ãã«ã¯çŽ128nïœïŒmlã§ã
ã€ãã
ãè¡šã
ïŒ ããªã¢ã¯ãªã«ã¢ããïŒäžäº
ãµã€ã¢ããã瀟補
åèšäœ¿çšäŸïŒã«ç€ºãåã®ãã©ã¹ã¿ãŒæ§é äœã¯å
çš®ã®ç®èçŸæ£ã®æ²»çä¹è³çŸå®¹çšæ é€å€ã®æµžéçã®
ç®çã«ãæçšã§ããããšãæããã§ãããã äŸãã°äž¡å°åã®å°é»æ§ã²ã«å±€ãååº
GANTREZR ANâ169 20ééïŒ ïŒ20ïŒ NaClå«
æèžçæ°Ž15ééïŒ åã³ã°ãªã»ãªã³65ïŒ ééïŒ ãã
æãåã1.5mmãé¢ç©çŽ12cm2ã®ç®èæ¥çæ§ãæã
ãç²åŒŸæ§ã²ã«ã§åœ¢æãããã®äœ¿çšæã«ãããŠãé¢
å°åã®å°é»æ§ã²ã«å±€ã«ïŒïŒ ã¢ã¹ã³ã«ãã³é žãããª
ãŠã å«æ氎溶液ïŒã¢ã³ãã«è²¯èµïŒïŒãæ°mlã滎äž
å«æµžãããã次ãã§æ£éšã«æ§é äœå šäœã貌çããŠ
æœè¡ãéå§ããã åšç¥ã®éãããã¿ãã³ïŒ£ïŒã¢ã¹ã³ã«ãã³é žïŒä¹
è³ãã®èªå°äœïŒã¢ã¹ã³ã«ãã³é žãããªãŠã çïŒ
ã¯ãæè¬èæïŒéåµæïŒåçš®é»ç®ççã®è²çŽ æ²ç
çã«æå¹ãªãã®ã§ãããã€ãªã³ãããªã¬ãŒãŒã«ã
ãæœè¡ãçŸå®¹ä¹è³ç®èç§ã«ãã€ãŠã¯æ¢ã«ãã®æçš
æ§ãç¥ãããŠãããã®ã§ããããåè¿°ã®éãæäœ
ã®ç ©éã«ããäžè¬ã«æ®åãèŠãŠããªããã®ã§ã
ãããããä¹ããæ¬äŸã¯ããã«ããã°æ¥µããŠç°¡æ
ãªæäœã§åœè©²æœè¡å¯èœãšãªããã®ã§ãããæ²»çä¹
è³çŸå®¹çšãã©ã¹ã¿ãŒãšããŠç»æçãªãã®ãšäºãåŸ
ãã ãã®ä»ã®ã²ã«åºæ æ¬çºæå°é»æ§ã²ã«å±€ã®ã²ã«åºæã®å¥œé©äŸã®å¹Ÿã€
ãã¯å è¿°ããéãã§ããããæŽã«æè¬çäœçšé»æ¥µ
ææçãšããŠå ¬ç¥ã®å€æ§ãªèŠªæ°Žæ§é«ååæãéæ
ã«éžæ䜿çšããåŸããã®ã§ããããšãæ¹ããŠææ
ããããäŸãã°ã ç¹éæ52幎95895å·ïŒ å54幎77489å· å 55幎52742å·ïŒ å55幎81635å· å 55幎129035å·ïŒ å56幎15728å· å 56幎63939å·ïŒ å56幎36940å· å 56幎60534å·ïŒ å56幎89270å· å 56幎143141å·ïŒ å57幎28505å· å 57幎49431å·ïŒ å57幎52463å· å 57幎55132å·ïŒ å57幎131428å· å 57幎160439å·ïŒ å57幎164064å· å 57幎166142å·ïŒ å57幎168675å· å 57幎4569å·ïŒ å58幎10066å· å®éæ54幎80689å·ïŒ å56幎135706å· å 56幎138603å·ïŒ å57幎93305å· å 57幎179413å·ïŒ å57幎185309å· çã ã«é瀺ã®å皮芪氎æ§é«ååæã¯ããã®å«æ°Žç
çãé©å®èª¿æŽããããšã«ããæ¬çºæå°é»æ§ã²ã«å±€
ã®ã²ã«åºæãšããŠäœ¿çšãåŸããã®ã§ããã ãã®ããã«ãæ¬çºæå°é»æ§ã²ã«å±€ã®ã²ã«åºæã¯
芪氎æ§é«ååã§ãã€ãŠæ°Žåã³ïŒåã¯ã¢ã«ã³ãŒã«é¡
ã«ããæè»å¯å¡åãããŠã奜ãŸããã¯ãç®èæ¥ç
æ§ã®ç²åŒŸæ§ã²ã«ãäžãããã®ã§ããã°è¶³ããç¹å®
æã«éå®ããããã®ã§ã¯ãªãã䜿çšè¬å€ãšã®é©å
æ§ãç®èé©åæ§åã³å°é»æ§çãèæ ®ããŠãã®åºæ
çµæã決å®ããããåããããã²ã«å±€ã䜿ãæšãŠ
ãããã¯ä»ã®å€«ãšå€æããããšçã¯èªåšã§ããã
ãµã€ã¢ããã瀟補
åèšäœ¿çšäŸïŒã«ç€ºãåã®ãã©ã¹ã¿ãŒæ§é äœã¯å
çš®ã®ç®èçŸæ£ã®æ²»çä¹è³çŸå®¹çšæ é€å€ã®æµžéçã®
ç®çã«ãæçšã§ããããšãæããã§ãããã äŸãã°äž¡å°åã®å°é»æ§ã²ã«å±€ãååº
GANTREZR ANâ169 20ééïŒ ïŒ20ïŒ NaClå«
æèžçæ°Ž15ééïŒ åã³ã°ãªã»ãªã³65ïŒ ééïŒ ãã
æãåã1.5mmãé¢ç©çŽ12cm2ã®ç®èæ¥çæ§ãæã
ãç²åŒŸæ§ã²ã«ã§åœ¢æãããã®äœ¿çšæã«ãããŠãé¢
å°åã®å°é»æ§ã²ã«å±€ã«ïŒïŒ ã¢ã¹ã³ã«ãã³é žãããª
ãŠã å«æ氎溶液ïŒã¢ã³ãã«è²¯èµïŒïŒãæ°mlã滎äž
å«æµžãããã次ãã§æ£éšã«æ§é äœå šäœã貌çããŠ
æœè¡ãéå§ããã åšç¥ã®éãããã¿ãã³ïŒ£ïŒã¢ã¹ã³ã«ãã³é žïŒä¹
è³ãã®èªå°äœïŒã¢ã¹ã³ã«ãã³é žãããªãŠã çïŒ
ã¯ãæè¬èæïŒéåµæïŒåçš®é»ç®ççã®è²çŽ æ²ç
çã«æå¹ãªãã®ã§ãããã€ãªã³ãããªã¬ãŒãŒã«ã
ãæœè¡ãçŸå®¹ä¹è³ç®èç§ã«ãã€ãŠã¯æ¢ã«ãã®æçš
æ§ãç¥ãããŠãããã®ã§ããããåè¿°ã®éãæäœ
ã®ç ©éã«ããäžè¬ã«æ®åãèŠãŠããªããã®ã§ã
ãããããä¹ããæ¬äŸã¯ããã«ããã°æ¥µããŠç°¡æ
ãªæäœã§åœè©²æœè¡å¯èœãšãªããã®ã§ãããæ²»çä¹
è³çŸå®¹çšãã©ã¹ã¿ãŒãšããŠç»æçãªãã®ãšäºãåŸ
ãã ãã®ä»ã®ã²ã«åºæ æ¬çºæå°é»æ§ã²ã«å±€ã®ã²ã«åºæã®å¥œé©äŸã®å¹Ÿã€
ãã¯å è¿°ããéãã§ããããæŽã«æè¬çäœçšé»æ¥µ
ææçãšããŠå ¬ç¥ã®å€æ§ãªèŠªæ°Žæ§é«ååæãéæ
ã«éžæ䜿çšããåŸããã®ã§ããããšãæ¹ããŠææ
ããããäŸãã°ã ç¹éæ52幎95895å·ïŒ å54幎77489å· å 55幎52742å·ïŒ å55幎81635å· å 55幎129035å·ïŒ å56幎15728å· å 56幎63939å·ïŒ å56幎36940å· å 56幎60534å·ïŒ å56幎89270å· å 56幎143141å·ïŒ å57幎28505å· å 57幎49431å·ïŒ å57幎52463å· å 57幎55132å·ïŒ å57幎131428å· å 57幎160439å·ïŒ å57幎164064å· å 57幎166142å·ïŒ å57幎168675å· å 57幎4569å·ïŒ å58幎10066å· å®éæ54幎80689å·ïŒ å56幎135706å· å 56幎138603å·ïŒ å57幎93305å· å 57幎179413å·ïŒ å57幎185309å· çã ã«é瀺ã®å皮芪氎æ§é«ååæã¯ããã®å«æ°Žç
çãé©å®èª¿æŽããããšã«ããæ¬çºæå°é»æ§ã²ã«å±€
ã®ã²ã«åºæãšããŠäœ¿çšãåŸããã®ã§ããã ãã®ããã«ãæ¬çºæå°é»æ§ã²ã«å±€ã®ã²ã«åºæã¯
芪氎æ§é«ååã§ãã€ãŠæ°Žåã³ïŒåã¯ã¢ã«ã³ãŒã«é¡
ã«ããæè»å¯å¡åãããŠã奜ãŸããã¯ãç®èæ¥ç
æ§ã®ç²åŒŸæ§ã²ã«ãäžãããã®ã§ããã°è¶³ããç¹å®
æã«éå®ããããã®ã§ã¯ãªãã䜿çšè¬å€ãšã®é©å
æ§ãç®èé©åæ§åã³å°é»æ§çãèæ ®ããŠãã®åºæ
çµæã決å®ããããåããããã²ã«å±€ã䜿ãæšãŠ
ãããã¯ä»ã®å€«ãšå€æããããšçã¯èªåšã§ããã
第ïŒå³ã¯ç®èãç䟡åè·¯ã«çœ®æãã説æå³ã第
ïŒå³ã¯åŸæ¥ã®ã€ãªã³ãããªã¬ãŒãŒã«ããã波圢ã
瀺ããïœã¯ãã®ãã«ã¹é»å§æ³¢åœ¢å³ãïœã¯ïœã®æ³¢åœ¢
ãå°å ããæã«äººäœã«æµããé»æµæ³¢åœ¢å³ãïœã¯ïœ
ã®ããŠãŒãã€æ¯ãå°ãããããã«ã¹ãå°å ããå Ž
åã®é»æµæ³¢åœ¢å³ã瀺ãã 第ïŒå³ã¯æ¬çºæã€ãªã³ãããªã¬ãŒãŒçšããã€ã¹
ã®å®æœäŸã瀺ããããã¯åè·¯å³ã§ã第ïŒå³ã¯ãã®
æ²»çãã«ã¹åºåæã®éåè·¯å³ã瀺ãã第ïŒå³ã¯æ²»
çãã«ã¹äŒæ¢æã®éåè·¯å³ã瀺ãã第ïŒå³ïœã¯å°
åããåºåãããæ²»çãã«ã¹é»å§æ³¢åœ¢å³ã瀺ãã
ïœã¯ïœã®æ³¢åœ¢ãå°å ããæã«äººäœã«æµããé»æµæ³¢
圢å³ã瀺ãã第ïŒå³åã³ç¬¬ïŒå³ã¯æ¬çºæã€ãªã³ã
ããªã¬ãŒãŒçšããã€ã¹ã®ãã詳现ãªäžå®æœäŸã瀺
ããããã¯åè·¯å³ã瀺ãã第ïŒå³åã³ç¬¬ïŒïŒå³ã¯
æ¬çºæã€ãªã³ãããªã¬ãŒãŒçšããã€ã¹ã®å šäœæ§æ
ã®ç¬¬ïŒã®å®æœäŸã瀺ãã第ïŒå³ã¯âç·ã«æ²¿ã€
ãæé¢å³ã第ïŒïŒå³ã¯åºé¢å³ã瀺ãã第ïŒïŒå³å
ã³ç¬¬ïŒïŒå³ã¯å第ïŒã®å®æœäŸã瀺ã第ïŒïŒå³ã¯XI
âXIç·ã«æ²¿ã€ãæé¢å³ã第ïŒïŒå³ã¯æèŠå³ã瀺
ãã第ïŒïŒå³åã³ç¬¬ïŒïŒå³ã¯å第ïŒåã³ç¬¬ïŒã®å®
æœäŸã瀺ãã第ïŒïŒå³ã¯ãã®æé¢å³ã第ïŒïŒå³ã¯
ãã®æèŠå³ã瀺ãã âŠç®èãRdcâŠãªãŒã æµæãâŠå極ã€ã³ã
ãŒãã³ã¹ãRpolâŠå極æµæãCpolâŠå極容éã
ïŒâŠã€ãªã³ãããªã¬ãŒãŒçšããã€ã¹ãïŒâŠé»æºã
ïŒâŠãã«ã¹çºæ¯æ©æ§ãïŒâŠé¢å°åãïŒâŠäžé¢å°
åãïŒâŠäººäœãïŒâŠã³ã³ãã³ãµïŒæ®åé»è·ååçš
ãã€ãã·ã¿ïŒãïŒâŠã€ã³ãã¯ã¿ãïŒâŠã¹ã€ããã³
ã°ãã©ã³ãžã¹ã¿ãïŒïŒïŒïŒïŒâŠæ²»çãã«ã¹ãïŒïŒ
âŠãã©ã³ã¹ãïŒïŒâŠèªå°é»æµèªèµ·ãã©ã³ã¹ãïŒïŒ
âŠïŒæ¬¡åŽãïŒïŒâŠïŒæ¬¡åŽãïŒïŒâŠïŒæ¬¡é»æ± ãïœ
âŠãã«ã¹é»æµãïœâŠè±å極é»æµãïŒïŒïŒïŒïŒïŒ
ïŒïŒïŒïŒïŒâŠã€ãªã³ãããªã¬ãŒãŒçšããã€ã¹ãïŒ
ïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒâŠé¢å°åãïŒïŒïŒïŒïŒïŒïŒ
ïŒïŒïŒïŒâŠäžé¢å°åãïŒïŒïŒïŒïŒâŠã€ãªã³æ§è¬å€
å«æå°é»æ§ã²ã«å±€ãïŒïŒâŠå°é»æ§ã²ã«å±€ãïŒïŒïŒ
ïŒïŒïŒïŒïŒïŒïŒïŒâŠãã¯ãŒãµãã©ã€ãŠãããã
ïŒå³ã¯åŸæ¥ã®ã€ãªã³ãããªã¬ãŒãŒã«ããã波圢ã
瀺ããïœã¯ãã®ãã«ã¹é»å§æ³¢åœ¢å³ãïœã¯ïœã®æ³¢åœ¢
ãå°å ããæã«äººäœã«æµããé»æµæ³¢åœ¢å³ãïœã¯ïœ
ã®ããŠãŒãã€æ¯ãå°ãããããã«ã¹ãå°å ããå Ž
åã®é»æµæ³¢åœ¢å³ã瀺ãã 第ïŒå³ã¯æ¬çºæã€ãªã³ãããªã¬ãŒãŒçšããã€ã¹
ã®å®æœäŸã瀺ããããã¯åè·¯å³ã§ã第ïŒå³ã¯ãã®
æ²»çãã«ã¹åºåæã®éåè·¯å³ã瀺ãã第ïŒå³ã¯æ²»
çãã«ã¹äŒæ¢æã®éåè·¯å³ã瀺ãã第ïŒå³ïœã¯å°
åããåºåãããæ²»çãã«ã¹é»å§æ³¢åœ¢å³ã瀺ãã
ïœã¯ïœã®æ³¢åœ¢ãå°å ããæã«äººäœã«æµããé»æµæ³¢
圢å³ã瀺ãã第ïŒå³åã³ç¬¬ïŒå³ã¯æ¬çºæã€ãªã³ã
ããªã¬ãŒãŒçšããã€ã¹ã®ãã詳现ãªäžå®æœäŸã瀺
ããããã¯åè·¯å³ã瀺ãã第ïŒå³åã³ç¬¬ïŒïŒå³ã¯
æ¬çºæã€ãªã³ãããªã¬ãŒãŒçšããã€ã¹ã®å šäœæ§æ
ã®ç¬¬ïŒã®å®æœäŸã瀺ãã第ïŒå³ã¯âç·ã«æ²¿ã€
ãæé¢å³ã第ïŒïŒå³ã¯åºé¢å³ã瀺ãã第ïŒïŒå³å
ã³ç¬¬ïŒïŒå³ã¯å第ïŒã®å®æœäŸã瀺ã第ïŒïŒå³ã¯XI
âXIç·ã«æ²¿ã€ãæé¢å³ã第ïŒïŒå³ã¯æèŠå³ã瀺
ãã第ïŒïŒå³åã³ç¬¬ïŒïŒå³ã¯å第ïŒåã³ç¬¬ïŒã®å®
æœäŸã瀺ãã第ïŒïŒå³ã¯ãã®æé¢å³ã第ïŒïŒå³ã¯
ãã®æèŠå³ã瀺ãã âŠç®èãRdcâŠãªãŒã æµæãâŠå極ã€ã³ã
ãŒãã³ã¹ãRpolâŠå極æµæãCpolâŠå極容éã
ïŒâŠã€ãªã³ãããªã¬ãŒãŒçšããã€ã¹ãïŒâŠé»æºã
ïŒâŠãã«ã¹çºæ¯æ©æ§ãïŒâŠé¢å°åãïŒâŠäžé¢å°
åãïŒâŠäººäœãïŒâŠã³ã³ãã³ãµïŒæ®åé»è·ååçš
ãã€ãã·ã¿ïŒãïŒâŠã€ã³ãã¯ã¿ãïŒâŠã¹ã€ããã³
ã°ãã©ã³ãžã¹ã¿ãïŒïŒïŒïŒïŒâŠæ²»çãã«ã¹ãïŒïŒ
âŠãã©ã³ã¹ãïŒïŒâŠèªå°é»æµèªèµ·ãã©ã³ã¹ãïŒïŒ
âŠïŒæ¬¡åŽãïŒïŒâŠïŒæ¬¡åŽãïŒïŒâŠïŒæ¬¡é»æ± ãïœ
âŠãã«ã¹é»æµãïœâŠè±å極é»æµãïŒïŒïŒïŒïŒïŒ
ïŒïŒïŒïŒïŒâŠã€ãªã³ãããªã¬ãŒãŒçšããã€ã¹ãïŒ
ïŒïŒïŒïŒïŒïŒïŒïŒïŒïŒâŠé¢å°åãïŒïŒïŒïŒïŒïŒïŒ
ïŒïŒïŒïŒâŠäžé¢å°åãïŒïŒïŒïŒïŒâŠã€ãªã³æ§è¬å€
å«æå°é»æ§ã²ã«å±€ãïŒïŒâŠå°é»æ§ã²ã«å±€ãïŒïŒïŒ
ïŒïŒïŒïŒïŒïŒïŒïŒâŠãã¯ãŒãµãã©ã€ãŠãããã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ é»æºãšãã«ã¹çºæ¯æ©æ§ãšé¢å°ååã³äžé¢å°å
ãšãæããã€ãªã³ãããªã¬ãŒãŒçšããã€ã¹ã«ãã
ãŠãåèšãã«ã¹çºæ¯æ©æ§ã®æ²»çãã«ã¹äŒæ¢æã«å
èšäž¡å°åéãè±å極ãããšãšãã«ãå極容éã«è²¯
ããããæ®åé»è·ãååããæ段ãèšããããšã
ç¹åŸŽãšããã€ãªã³ãããªã¬ãŒãŒçšããã€ã¹ã ïŒ ã€ã³ãã¯ã¿ãäž¡å°åéã«çŽåã«èšãããã®ã€
ã³ãã¯ã¿ã³ã¹ãšè² è·å®¹éãšã®ïŒ¬âïŒ£å ±æ¯ã«ããå
極容éã«è²¯ããããæ®åé»è·ãè±å極ãããšãšã
ã«ååããããšãç¹åŸŽãšããåèšç¹èš±è«æ±ã®ç¯å²
第ïŒé èšèŒã®ã€ãªã³ãããªã¬ãŒãŒçšããã€ã¹ã ïŒ ã€ã³ãã¯ã¿ã¯ããã«ã¹é»å§æå§çšã®ãã©ã³ã¹
ãå©çšããããšãç¹åŸŽãšããåèšç¹èš±è«æ±ã®ç¯å²
第ïŒé ãŸãã¯ç¬¬ïŒé èšèŒã®ã€ãªã³ãããªã¬ãŒãŒçš
ããã€ã¹ã ïŒ å極容éã«è²¯ããããæ®åé»è·ãè±å極ãã
ãšãšãã«ååããããã«ãèªå°é»æµèªèµ·ãã©ã³ã¹
ãèšãããã®ãã©ã³ã¹ã®ïŒæ¬¡åŽãäž¡å°åéã«çŽå
ã«æ¥ç¶ãããšãšãã«ïŒæ¬¡åŽãïŒæ¬¡é»æ± ãŸãã¯ã³ã³
ãã³ãµã«æ¥ç¶ããããšãç¹åŸŽãšããåèšç¹èš±è«æ±
ã®ç¯å²ç¬¬ïŒé èšèŒã®ã€ãªã³ãããªã¬ãŒãŒçšããã€
ã¹ã
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP15131084A JPS6131169A (ja) | 1984-07-23 | 1984-07-23 | ã€ãªã³ããã©ã¬âãŒçšããã€ã¹ |
| CA000461979A CA1262564A (en) | 1983-09-01 | 1984-08-28 | Iontophoresis device |
| EP88103452A EP0308572B1 (en) | 1983-09-01 | 1984-08-29 | An iontophoresis device |
| DE8484305910T DE3479191D1 (en) | 1983-09-01 | 1984-08-29 | An iontophoresis device |
| AU32492/84A AU575068B2 (en) | 1983-09-01 | 1984-08-29 | Iontophoresis device |
| EP84305910A EP0138347B1 (en) | 1983-09-01 | 1984-08-29 | An iontophoresis device |
| DE3486412T DE3486412T2 (de) | 1983-09-01 | 1984-08-29 | IontophoresegerÀt. |
| US06/792,245 US4764164A (en) | 1983-09-01 | 1985-10-30 | Iontophoresis device |
| AU18506/88A AU599493B2 (en) | 1983-09-01 | 1988-06-29 | An iontophoresis device |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP15131084A JPS6131169A (ja) | 1984-07-23 | 1984-07-23 | ã€ãªã³ããã©ã¬âãŒçšããã€ã¹ |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6131169A JPS6131169A (ja) | 1986-02-13 |
| JPH041634B2 true JPH041634B2 (ja) | 1992-01-13 |
Family
ID=15515855
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP15131084A Granted JPS6131169A (ja) | 1983-09-01 | 1984-07-23 | ã€ãªã³ããã©ã¬âãŒçšããã€ã¹ |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6131169A (ja) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5042975A (en) * | 1986-07-25 | 1991-08-27 | Rutgers, The State University Of New Jersey | Iontotherapeutic device and process and iontotherapeutic unit dose |
| EP0313638A4 (en) * | 1987-05-15 | 1989-06-14 | Martin H Newman | IONTOPHORESIS INOPHORESIS DRUG ADMINISTRATION SYSTEM. |
| JP7540688B2 (ja) * | 2020-04-20 | 2024-08-27 | éç° çžå | é»æ°æ²»ççšç«¯ååã³é»æ°æ²»ççšè£ 眮 |
-
1984
- 1984-07-23 JP JP15131084A patent/JPS6131169A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6131169A (ja) | 1986-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4764164A (en) | Iontophoresis device | |
| JP3119486B2 (ja) | ã€ãªã³ããã©ã¬ãŒã·ã¹çšé»æ¥µåã³ãããçšããããã€ã¹ | |
| JP4165659B2 (ja) | å®å šæ§ãæ¹è¯ãããä¹±çšå¯èœæ§ãäœäžããé»æ°ç移éåŒæäžããã€ã¹ | |
| JPH0217186B2 (ja) | ||
| US7643874B2 (en) | Dermal patch | |
| AU637674B2 (en) | Method and apparatus for pulsed iontophoretic drug delivery | |
| CN1607970B (zh) | ç®è€èŽŽç | |
| US7979117B2 (en) | Device and method for controlled delivery of active substance into the skin | |
| JPH0245461B2 (ja) | ||
| EP0308572B1 (en) | An iontophoresis device | |
| JPWO1995035132A1 (ja) | ã€ãªã³ããã©ã¬ãŒã·ã¹çšé»æ¥µåã³ãããçšããããã€ã¹ | |
| US20100228180A1 (en) | Power Source Electrode Treatment Device | |
| WO2007106270A2 (en) | Stimulating galvanic or slow ac current for therapeutic physiological effects | |
| JP2816886B2 (ja) | çäœéé»è£ 眮 | |
| JPH04224770A (ja) | ã€ãªã³ããã©ã¬ãŒã·ã¹çšè£ 眮 | |
| JPH0852224A (ja) | ã€ãªã³ããã©ã¬ãŒã·ã¹çšããã€ã¹ | |
| JPS60188176A (ja) | ã€ãªã³ãããªã¬âãŒçšããã€ã¹ | |
| JPH041634B2 (ja) | ||
| JPH0217187B2 (ja) | ||
| JP2839279B2 (ja) | ã€ãªã³ããã©ã¬ãŒãŒçšããã€ã¹ | |
| JPH0349589B2 (ja) | ||
| JPH0248262B2 (ja) | ||
| JP3119488B2 (ja) | 氎溶æ§ã¹ããã€ãçšã€ãªã³ããã©ã¬ãŒã·ã¹ããã€ã¹ | |
| JP3761201B2 (ja) | ã€ãªã³ããã©ã¬ãŒã·ã¹çšããã€ã¹ | |
| JP3761201B6 (ja) | ã€ãªã³ããã©ã¬ãŒã·ã¹çšããã€ã¹ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EXPY | Cancellation because of completion of term |